http://jnci.oxfordjournals.org/content/106/5/dju048.full
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
      xmlns="http://www.w3.org/1999/xhtml"
      xml:lang="en"
      lang="en">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples </title>
      <meta name="googlebot" content="NOODP" />
      <meta name="HW.ad-path" content="/cgi/content/full/106/5/dju048" />
      <meta content="/jnci/106/5/dju048.atom" name="HW.identifier" />
      <meta name="DC.Format" content="text/html" />
      <meta name="DC.Language" content="en" />
      <meta content="Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples"
            name="DC.Title" />
      <meta content="10.1093/jnci/dju048" name="DC.Identifier" />
      <meta content="2014-05-01" name="DC.Date" />
      <meta content="Oxford University Press" name="DC.Publisher" />
      <meta content="Markus Riester" name="DC.Contributor" />
      <meta content="Wei Wei" name="DC.Contributor" />
      <meta content="Levi Waldron" name="DC.Contributor" />
      <meta content="Aedin C. Culhane" name="DC.Contributor" />
      <meta content="Lorenzo Trippa" name="DC.Contributor" />
      <meta content="Esther Oliva" name="DC.Contributor" />
      <meta content="Sung-hoon Kim" name="DC.Contributor" />
      <meta content="Franziska Michor" name="DC.Contributor" />
      <meta content="Curtis Huttenhower" name="DC.Contributor" />
      <meta content="Giovanni Parmigiani" name="DC.Contributor" />
      <meta content="Michael J. Birrer" name="DC.Contributor" />
      <meta content="Journal of the National Cancer Institute"
            name="citation_journal_title" />
      <meta content="JNCI J Natl Cancer Inst" name="citation_journal_abbrev" />
      <meta content="0027-8874" name="citation_issn" />
      <meta content="1460-2105" name="citation_issn" />
      <meta name="citation_author" content="Markus Riester" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK)." />
      <meta name="citation_author" content="Wei Wei" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK)." />
      <meta name="citation_author" content="Levi Waldron" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK)." />
      <meta name="citation_author" content="Aedin C. Culhane" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK)." />
      <meta name="citation_author" content="Lorenzo Trippa" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK)." />
      <meta name="citation_author" content="Esther Oliva" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK)." />
      <meta name="citation_author" content="Sung-hoon Kim" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK)." />
      <meta name="citation_author" content="Franziska Michor" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK)." />
      <meta name="citation_author" content="Curtis Huttenhower" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK)." />
      <meta name="citation_author" content="Giovanni Parmigiani" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK)." />
      <meta name="citation_author" content="Michael J. Birrer" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors:&#xA;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK)." />
      <meta content="Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples"
            name="citation_title" />
      <meta content="05/01/2014" name="citation_date" />
      <meta content="106" name="citation_volume" />
      <meta content="5" name="citation_issue" />
      <meta content="dju048" name="citation_firstpage" />
      <meta content="106/5/dju048" name="citation_id" />
      <meta content="106/5/dju048" name="citation_id_from_sass_path" />
      <meta content="jnci;106/5/dju048" name="citation_mjid" />
      <meta content="10.1093/jnci/dju048" name="citation_doi" />
      <meta content="http://jnci.oxfordjournals.org/content/106/5/dju048.abstract"
            name="citation_abstract_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/106/5/dju048.full"
            name="citation_fulltext_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/106/5/dju048.full.pdf"
            name="citation_pdf_url" />
      <meta content="/content/106/5.cover.gif" name="issue_cover_image" />
      <meta content="http://jnci.oxfordjournals.org/content/106/5/dju048"
            name="citation_public_url" />
      <meta content="24700803" name="citation_pmid" />
      <meta name="citation_section" content="Article" />
      <meta name="robots" content="noarchive,nofollow" />
      <meta name="googlebot" content="noarchive" />
      <link href="/content/106/5/dju044.short" rel="prev" />
      <link href="/content/106/5/dju049.short" rel="next" />
      <link rel="stylesheet" type="text/css" media="all" href="/shared/css/hw-global.css" />
      <link rel="stylesheet" type="text/css" media="print" href="/shared/css/hw-print.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/local/css/hw-local-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-ac.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/jquery.fancybox-1.3.4.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-global-colexpand.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-page-content.css" /><script type="text/javascript" id="session-d28890608e1">var callbackToken='53733874D831D21';</script><script type="text/javascript" id="session-d28890608e3">
                      var subCode='oupjournal_sub';
                    </script><script type="text/javascript">
            var gAuthTimeStamp = '2015-10-27T12:12:46.759-07:00';
            var gSessionId = 'iwQMoDJGUrgdPqUAazk5EQ';
            var gAuthzRequired = 'false';
            var gAuthnMethods1 = 'ip ip';
            var gAuthnMethods2 = 'ip,ip';
            var gAuthnIPs = '18.189.59.169,18.189.59.169';
            var gAuthnIndividuals = '';
            var gAuthnInstitutions = '10005282,10072538,10328193,100274300,10082403,05094000,10093227,153074108,10080507,21879000,10095822,10081742,10082405,10004595,10019502,10082401,07635000,10082404,06602000';
            </script><script type="text/javascript" src="/shared/js/jquery-min.js"></script><script type="text/javascript" src="/shared/js/fingerprint.js"></script><script type="text/javascript" src="/shared/js/hw-shared.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-site.js"></script><script type="text/javascript" src="/local/js/local-js-vars.js"></script><script type="text/javascript" src="/shared/js/pages/hw-content.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.easing-1.3.pack.js"></script><script type="text/javascript"
              src="/shared/js/fancybox/jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="/shared/js/util/content.jquery.addVariantLink.js"></script><script type="text/javascript" src="/shared/js/util/hw-col-expand.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-modalwin-vars.js"></script><script type="text/javascript"
              src="/publisher/js/hw-publisher-article-dynamic-elements.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-content.js"></script><script type="text/javascript" src="/shared/js/util/hw-mathjax.js"></script><script type="text/x-mathjax-config">
          MathJax.Hub.Config({
              tex2jax: {
                inlineMath: [["$","$"],["\\(","\\)"]],
                processClass: "tex2jax_process|mathjax"
              }
            });
          MathJax.Hub.Queue(function() {
            gColTempResize = true;
            fixColHeights(1);
            gColTempResize = false;
          });
       </script><script type="text/javascript"
              src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script><script type="text/javascript">
	    
	    
	    
	    var siqDOI = encodeURIComponent("10.1093/jnci/dju048");
	    var siqIsOpenAccess = encodeURIComponent("");
	    var siqPubDate = encodeURIComponent("20140501");

	    if (siqDOI.length == 0) {
	        siqDOI = "UNKNOWN";
	    }
	    
	    
		
		
	    if (gAuthnIndividuals.length != 0) {
		if (gAuthnInstitutions.length != 0) {
		    authnEntity = encodeURIComponent(gAuthnIndividuals
		        + ',' + gAuthnInstitutions);
		} else {
		    authnEntity = encodeURIComponent(gAuthnIndividuals);
		}
	    } else {
	        authnEntity = encodeURIComponent(gAuthnInstitutions);
	    }

	    var commonString =
		'authSessionId=' + gSessionId + String.fromCharCode(0x26)
		+ 'authzRequired=' + gAuthzRequired + String.fromCharCode(0x26)
		+ 'authentication_method=' + encodeURIComponent(gAuthnMethods2) + String.fromCharCode(0x26)
		+ 'authnIPs=' + gAuthnIPs + String.fromCharCode(0x26)
		+ 'authnInstitutions=' + authnEntity;

		
		
		
		

	    var gPageId = "pageid-content";
	    var gVariant = "full-text";

	    
		// Not completely done
		var eventType = "full-text";
		var accessType;
		if (siqIsOpenAccess == 'true') {
		    accessType = 'SOA';
		} else {
		    accessType = 'subscription';
		}
		    
		var NTPT_PGEXTRA =
		    commonString + String.fromCharCode(0x26)
		    + 'event_type=' + eventType + String.fromCharCode(0x26)
		    + 'publication_date=' + siqPubDate + String.fromCharCode(0x26)
		    + 'access_type=' + accessType + String.fromCharCode(0x26)
		    + 'doi=' + siqDOI ;
		    
		

	    // alert("NTPT_PGEXTRA is " + NTPT_PGEXTRA);
	</script><link rel="stylesheet" type="text/css" media="all" href="/resource/css/hw20.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-header.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-footer.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-sidebars.css" />
      <link type="text/css" media="all" rel="stylesheet" href="/site/resource/jnci_h20.css" />
      <link rel="stylesheet" type="text/css" href="/resource/css/print.css" media="print" /><script type="text/javascript" src="/resource/js/main.js"></script><link rel="stylesheet" type="text/css" media="all"
            href="http://oi-underbar.ifactory.com/underbar/css/pf_oiunderbar.css" />
      <link rel="stylesheet" type="text/css" media="screen"
            href="http://gab.cookie.oup.com/aws-cookie/jquery.fancybox-1.3.4_1.css" /><script type="text/javascript" src="/resource/js/oup_ad_size.js"></script></head>
   <body class="general_page journal jnci">
      <div class="hw-gen-page pagetype-content hw-pub-id-article" id="pageid-content"
           itemscope="itemscope"
           itemtype="http://schema.org/ScholarlyArticle">
         <noscript>
            <p>We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of
               cookies. You can change your cookie settings at any time. <a href="http://global.oup.com/cookiepolicy/">Find out more</a></p>
         </noscript>
         
         
         <p class="hide">
            <a href="#content">Skip Navigation</a>
            
         </p>
         
         
         <div id="secondary_nav">
            <strong id="page_logo" title="Oxford Journals"><a href="http://www.oxfordjournals.org/"><span>Oxford Journals</span></a></strong>
            
            <ul>
               <li id="nav_contact_us" title="Contact Us"><a href="http://www.oxfordjournals.org/contact_us.html"><span>Contact Us</span></a></li>
               <li id="nav_my_basket" title="My Basket"><a href="https://secure.oxfordjournals.org/basket.html"><span>My Basket</span></a></li>
               <li id="nav_my_account" title="My Account"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http://www.oxfordjournals.org/service/Register"><span>My 
                        
                        Account</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="header">
            
            <h1 id="page_title" title="JNCI J Natl Cancer Inst"><a href="/"><span>
                     JNCI J Natl Cancer Inst
                     </span></a></h1>
            
         </div>
         
         
         <div id="primary_nav">
            
            <ul>
               <li id="nav_about_this_journal" title="About This Journal">
                  <a href="http://www.oxfordjournals.org/jnci/about.html">
                     
                     <span>About This Journal</span>
                     </a>
                  
               </li>
               <li id="nav_contact_this_journal" title="Contact This Journal"><a href="/cgi/feedback/"><span>Contact This Journal</span></a></li>
               <li id="nav_subscriptions" title="Subscriptions">
                  <a href="http://www.oxfordjournals.org/jnci/access_purchase/buy_online.html">
                     
                     <span>Subscriptions</span>
                     </a>
                  
               </li>
               <li id="nav_current_issue" title="Current"><a href="/content/current"><span>View Current Issue (Volume 107 Issue 10 October 2015)</span></a></li>
               <li id="nav_archive" title="Archive"><a href="/content/by/year"><span>Archive</span></a></li>
               <li id="nav_search" title="Search"><a href="/search"><span>Search</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="user_nav">
            
            <div class="header-ac-elements">
               
               <div id="authstring">
                  
                  <ul>
                     <li class="subscr-ref">Institution:  MIT Libraries</li>
                     <li class="no-left-border">
                        <a href="/login?uri=http%3A%2F%2Fjnci.oxfordjournals.org%2Fcontent%2F106%2F5%2Fdju048.full">
                           Sign In as Personal Subscriber
                           </a>
                        
                     </li>
                  </ul>           
                  
               </div>   
               
            </div>
            
         </div>
         
         
         <ul id="site-breadcrumbs">
            <li class="first"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http%3A%2F%2Fwww.oxfordjournals.org">Oxford Journals</a></li>
            <li><span class="breadcrumb_subjects"><a href="http://www.oxfordjournals.org/subject/medicine/"
                     class="breadcrumb_subject">Medicine &amp; Health</a></span></li>
            <li><a href="/">JNCI J Natl Cancer Inst</a></li>
            <li><a href="/content/106/5.toc">
                  <span xmlns="" class="volume-value">Volume 106</span>
                  <span xmlns="" class="issue-value"> Issue 5</span></a></li>
            <li class="last">10.1093/jnci/dju048</li>
         </ul>
         
         
         
         
         <div id="oas_top" class="ad_hidden">
            <iframe id="id_advertframe_top"
                    src="/resource/htmlfiles/advert.html?p=Top&amp;u=jnci.oxfordjournals.org/content/106/5/dju048.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         <a name="content"></a>
         
         
         <div id="h20_page"></div>
         
         <div id="content-block">
            <div class="article fulltext-view " itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Markus+Riester&amp;sortspec=date&amp;submit=Submit">Markus Riester</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="/search?author1=Wei+Wei&amp;sortspec=date&amp;submit=Submit">Wei Wei</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-3" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Levi+Waldron&amp;sortspec=date&amp;submit=Submit">Levi Waldron</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-4" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Aedin+C.+Culhane&amp;sortspec=date&amp;submit=Submit">Aedin C. Culhane</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-5" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Lorenzo+Trippa&amp;sortspec=date&amp;submit=Submit">Lorenzo Trippa</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-6" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Esther+Oliva&amp;sortspec=date&amp;submit=Submit">Esther Oliva</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-7" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Sung-hoon+Kim&amp;sortspec=date&amp;submit=Submit">Sung-hoon Kim</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-8" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Franziska+Michor&amp;sortspec=date&amp;submit=Submit">Franziska Michor</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-9" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Curtis+Huttenhower&amp;sortspec=date&amp;submit=Submit">Curtis Huttenhower</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-10" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Giovanni+Parmigiani&amp;sortspec=date&amp;submit=Submit">Giovanni Parmigiani</a></span> and 
                     </li>
                     <li class="last" id="contrib-11"><span class="name"><a class="name-search"
                              href="/search?author1=Michael+J.+Birrer&amp;sortspec=date&amp;submit=Submit">Michael J. Birrer</a></span></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address>
                           <strong>Affiliations of authors:</strong>
                           Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, <span class="addr-line">Boston, MA</span> (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, <span class="addr-line">Boston, MA</span> (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General
                           Hospital, <span class="addr-line">Boston, MA</span>; City University of New York School of Public Health, Hunter College, <span class="addr-line">New York, NY</span> (LW); Sung-hoon Kim, Yonsei University College of Medicine, <span class="addr-line">Seoul</span>, Korea (S-HK).
                        </address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="corresp" id="corresp-1">
                        <strong>Correspondence to:</strong><br /> Michael J. Birrer, MD, PhD, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, 55 Fruit St, Boston,
                        MA 02114 (e-mail: <span class="em-link"><span class="em-addr">mbirrer{at}partners.org</span></span>).
                     </li>
                  </ol>
                  <ul class="history-list">
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="received"
                         hwp:start="2013-10-10"><span class="received-label">Received </span>October 10, 2013.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd"
                         hwp:start="2014-01-23"><span class="rev-recd-label">Revision received </span>January 23, 2014.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted"
                         hwp:start="2014-01-29"><span class="accepted-label">Accepted </span>January 29, 2014.
                     </li>
                  </ul>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder"> </div><a href="#sec-5" title="Methods" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Abstract</h2>
                  
                  <div id="sec-1" class="subsection">
                     
                     
                     <p id="p-1"><strong>Background</strong> Ovarian cancer causes more than 15000 deaths per year in the United States. The survival of patients is quite heterogeneous,
                        and accurate prognostic tools would help with the clinical management of these patients.
                     </p>
                     
                  </div>
                  
                  <div id="sec-2" class="subsection methods">
                     
                     
                     <p id="p-2"><strong>Methods</strong> We developed and validated two gene expression signatures, the first for predicting survival in advanced-stage, serous ovarian
                        cancer and the second for predicting debulking status. We integrated 13 publicly available datasets totaling 1525 subjects.
                        We trained prediction models using a meta-analysis variation on the compound covariable method, tested models by a “leave-one-dataset-out”
                        procedure, and validated models in additional independent datasets. Selected genes from the debulking signature were validated
                        by immunohistochemistry and quantitative reverse-transcription polymerase chain reaction (qRT-PCR) in two further independent
                        cohorts of 179 and 78 patients, respectively. All statistical tests were two-sided.
                     </p>
                     
                  </div>
                  
                  <div id="sec-3" class="subsection">
                     
                     
                     <p id="p-3"><strong>Results</strong> The survival signature stratified patients into high- and low-risk groups (hazard ratio = 2.19; 95% confidence interval [CI]
                        = 1.84 to 2.61) statistically significantly better than the TCGA signature (<em>P</em> = .04). <em>POSTN, CXCL14</em>, <em>FAP</em>, <em>NUAK1</em>, <em>PTCH1</em>, and <em>TGFBR2</em> were validated by qRT-PCR (<em>P</em> &lt; .05) and POSTN, CXCL14, and phosphorylated Smad2/3 were validated by immunohistochemistry (<em>P</em> &lt; .001) as independent predictors of debulking status. The sum of immunohistochemistry intensities for these three proteins
                        provided a tool that classified 92.8% of samples correctly in high- and low-risk groups for suboptimal debulking (area under
                        the curve = 0.89; 95% CI = 0.84 to 0.93).
                     </p>
                     
                  </div>
                  
                  <div id="sec-4" class="subsection">
                     
                     
                     <p id="p-4"><strong>Conclusions</strong> Our survival signature provides the most accurate and validated prognostic model for early- and advanced-stage high-grade,
                        serous ovarian cancer. The debulking signature accurately predicts the outcome of cytoreductive surgery, potentially allowing
                        for stratification of patients for primary vs secondary cytoreduction.
                     </p>
                     
                  </div>
                  
               </div>
               <p id="p-5">Ovarian cancer is the most lethal gynecologic malignancy, causing more than 15000 deaths per year in the United States (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>). Advanced ovarian cancer (stages III and IV) accounted for the majority of the estimated 22000 new cases of epithelial ovarian
                  cancer in 2012 in the United States (<a id="xref-ref-1-2" class="xref-bibr" href="#ref-1">1</a>). Improvements in the treatment of patients with advanced-stage ovarian cancers have extended women’s median survival, but
                  overall survival has not substantially changed. This results from effective upfront treatment of the disease but with subsequent
                  recurrence and the development of drug-resistant disease.
               </p>
               <p id="p-6" class="indent">The initial treatment for all patients with advanced-stage ovarian cancer is extensive debulking surgery, with the goal being
                  removal of tumor to less than 1cm. Patients who are optimally debulked (&lt;1cm residual disease) have a substantially improved
                  survival compared with patients who are left with bulky residual disease (&gt;1cm; suboptimally debulked). Suboptimally debulked
                  patients do not benefit from this extensive surgery (<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>,<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>). After surgery, all patients undergo combination chemotherapy that is effective in approximately 75% of patients (<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>). Thus, developing tools to stratify patients according to ability to be cytoreduced or response to primary chemotherapy
                  may help improve patient survival and minimize therapeutic toxicity. It is important to note, however, that most patients
                  with advanced-stage ovarian cancer ultimately suffer recurrence and eventually develop drug-resistant tumors. Thus the development
                  of new and novel therapies for this disease is absolutely critical.
               </p>
               <p id="p-7" class="indent">Our laboratory has developed the largest collection of ovarian cancer gene expression data to date (<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>), allowing us to systematically evaluate a range of previously published prognostic signatures (<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6–16</a>). We identified the signature developed by The Cancer Genome Atlas (TCGA) consortium as the best available prognostic model
                  (<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>). The TCGA consortium recently proposed an updated survival signature, trained on twice as many samples and incorporating
                  subtype information and clinicopathologic factors (<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>). However, it remains unclear whether prognostic accuracy can be improved with additional data.
               </p>
               <p id="p-8" class="indent">Here, we use a meta-analytic signature development approach to leverage more than 1500 publicly available, clinically annotated
                  microarray assays of high-grade, primary serous tumors to comprehensively address two objectives for patients with ovarian
                  cancer. These are 1) to develop a prognostic gene signature for overall survival of early- and late-stage patients and 2)
                  to predict suboptimal cytoreductive surgery. We performed extensive signature evaluation demonstrating significant improvement
                  over existing survival signatures. Furthermore, this work establishes the existence of a signature predictive for suboptimal
                  cytoreduction, providing the possibility that unsuccessful surgery can be avoided through a genomic or immunohistochemical
                  test at diagnosis.
               </p>
               <div class="section methods" id="sec-5">
                  <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-15" title="Results" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Methods</h2>
                  
                  <div id="sec-6" class="subsection">
                     
                     <h3>Dataset and Patient Eligibility Criteria</h3>
                     
                     <p id="p-9">Gene expression data on tumors, with carefully curated clinical annotations, are available in the curatedOvarianData database
                        (<a id="xref-ref-5-2" class="xref-bibr" href="#ref-5">5</a>). Criteria for inclusion of studies in this database, the corresponding literature reviews, and the data-processing protocols
                        have been described previously (<a id="xref-ref-5-3" class="xref-bibr" href="#ref-5">5</a>). We restricted our meta-analysis to primary, late-stage, high-grade, serous tumors with available overall survival time-to-event
                        data (<a id="xref-table-wrap-1-1" class="xref-table" href="#T1">Table 1</a>). For prediction model training, we required a minimum study sample size of 75. Only datasets published before March 2012
                        were considered in the training phase. Datasets that did not satisfy these two criteria were set aside as independent validation
                        data for the final model. This led to six training datasets and seven validation datasets. We also tested our final model
                        on the 27 early-stage, high-grade samples from TCGA; these samples contained eight patients with events. Datasets were systematically
                        screened for duplicated samples, as described previously (<a id="xref-ref-17-2" class="xref-bibr" href="#ref-17">17</a>).
                     </p>
                     
                     <div id="T1" class="table pos-float">
                        <div class="table-inline">
                           <div class="callout"><span>View this table:</span><ul class="callout-links">
                                 <li><a href="dju048/T1.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="dju048/T1.expansion.html">In a new window</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="table-caption"><span class="table-label">Table 1.</span> 
                           
                           <p id="p-10" class="first-child">Datasets used in this study*</p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                  </div>
                  
                  <div id="sec-7" class="subsection">
                     
                     <h3>Clinical Endpoints</h3>
                     
                     <p id="p-18">For the survival signature, the primary endpoint was overall survival from initial diagnosis to death. For the debulking signature,
                        suboptimal debulking was defined as residual tumor mass greater than 1cm, except for datasets (<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>) where we used presence of macroscopic residual tumor.
                     </p>
                     
                  </div>
                  
                  <div id="sec-8" class="subsection">
                     
                     <h3>Statistical Analysis</h3>
                     
                     <div id="sec-9" class="subsection">
                        
                        <h4>Overall Strategy.</h4>
                        
                        <p id="p-19">We trained the overall survival signature on the 6 training datasets (see <a id="xref-fig-1-1" class="xref-fig" href="#F1">Figure 1</a>). We then evaluated the performance in three ways: 1) a leave-one-dataset-out validation within the six training datasets
                           (see <a id="xref-fig-2-1" class="xref-fig" href="#F2">Figure 2</a>): here each dataset in turn is set aside for cross-study validation, and the model is trained on the remaining five datasets
                           to assess cross-study consistency (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 1</a>, available online); results of this step are not subject to optimistic bias. At the end of this phase a single model is trained
                           on all six training datasets; 2) independent validation on the seven validation datasets (see <a id="xref-fig-3-1" class="xref-fig" href="#F3">Figure 3</a>): none of the samples from the six training datasets are used in this step; and 3) joint visualization of the first two methods
                           to provide a summary view of both leave-one-study-out and independent validation performance (see <a id="xref-fig-4-1" class="xref-fig" href="#F4">Figure 4</a>). The third method has no effect on the training. In addition to cross-validation in public datasets (see <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 10</a>, available online), the debulking signature was validated in two independent cohorts by quantitative reverse-transcription
                           polymerase chain reaction (qRT-PCR) and immunohistochemistry (see <a id="xref-fig-5-1" class="xref-fig" href="#F5">Figures 6</a> and <a id="xref-fig-6-1" class="xref-fig" href="#F6">7</a>).
                        </p>
                        
                        <div id="F1" class="fig pos-float type-figure  odd">
                           <div class="fig-inline"><a href="dju048/F1.expansion.html"><img alt="Figure 1." src="dju048/F1.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                    <li><a href="dju048/F1.expansion.html">In this window</a></li>
                                    <li><a class="in-nw" href="dju048/F1.expansion.html">In a new window</a></li>
                                 </ul>
                                 <ul class="fig-services">
                                    <li class="ppt-link"><a href="/powerpoint/106/5/dju048/F1">Download as PowerPoint Slide</a></li>
                                 </ul>
                              </div>
                           </div>
                           <div class="fig-caption"><span class="fig-label">Figure 1.</span> 
                              
                              <p id="p-20" class="first-child">Flowchart of the study. This outlines the steps for training and validating the prognostic models presented in this study.
                                 * Including 27 TCGA early stage samples.
                              </p>
                              
                              <p id="p-21">†Samples that were included in multiple studies were identified and removed (see <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Table 1</a>, available online). qRT-PCR = quantitative reverse-transcription polymerase chain reaction.
                              </p>
                              
                              <div class="sb-div caption-clear"></div>
                           </div>
                        </div>
                        
                        <div id="F2" class="fig pos-float type-figure  odd">
                           <div class="fig-inline"><a href="dju048/F2.expansion.html"><img alt="Figure 2." src="dju048/F2.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                    <li><a href="dju048/F2.expansion.html">In this window</a></li>
                                    <li><a class="in-nw" href="dju048/F2.expansion.html">In a new window</a></li>
                                 </ul>
                                 <ul class="fig-services">
                                    <li class="ppt-link"><a href="/powerpoint/106/5/dju048/F2">Download as PowerPoint Slide</a></li>
                                 </ul>
                              </div>
                           </div>
                           <div class="fig-caption"><span class="fig-label">Figure 2.</span> 
                              
                              <p id="p-22" class="first-child">Leave-one-dataset-out validation of performance of the new gene signature in predicting overall survival in late-stage ovarian
                                 cancer. We used our database of the ovarian transcriptome (<a id="xref-ref-5-4" class="xref-bibr" href="#ref-5">5</a>) for developing a novel overall survival gene signature by a meta-analytic signature development method. In total, six large
                                 datasets passed our training criteria (see Methods). To first test our methodology on the six large datasets we used for training
                                 (<a id="xref-ref-6-2" class="xref-bibr" href="#ref-6">6</a>,<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-9-2" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>,<a id="xref-ref-63-1" class="xref-bibr" href="#ref-63">63</a>), we applied a leave-one-dataset-out approach (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 1</a>, available online). Specifically, for each of the six datasets, we trained a prediction model using the remaining five datasets
                                 only and then stratified the patients of the dataset not used for training into high- and low-risk groups. <em>P</em> values were calculated with the log-rank test, and cutoffs for patient stratification were the medians of predicted risk
                                 scores in the combined training cohorts. All statistical tests were two-sided. TCGA = The Cancer Genome Atlas.
                              </p>
                              
                              <div class="sb-div caption-clear"></div>
                           </div>
                        </div>
                        
                        <div id="F3" class="fig pos-float type-figure  odd">
                           <div class="fig-inline"><a href="dju048/F3.expansion.html"><img alt="Figure 3." src="dju048/F3.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                    <li><a href="dju048/F3.expansion.html">In this window</a></li>
                                    <li><a class="in-nw" href="dju048/F3.expansion.html">In a new window</a></li>
                                 </ul>
                                 <ul class="fig-services">
                                    <li class="ppt-link"><a href="/powerpoint/106/5/dju048/F3">Download as PowerPoint Slide</a></li>
                                 </ul>
                              </div>
                           </div>
                           <div class="fig-caption"><span class="fig-label">Figure 3.</span> 
                              
                              <p id="p-23" class="first-child">Validation of the survival signature in independent data (<a id="xref-ref-9-3" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-19-2" class="xref-bibr" href="#ref-19">19</a>,<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28–30</a>). <strong>A–E</strong>) Risk stratification in five validation microarray datasets of late-stage, high-grade, serous ovarian cancer by a model trained
                                 on all six training datasets (<a id="xref-fig-2-2" class="xref-fig" href="#F2">Figure 2</a>). The Gillet et al. reverse-transcription polymerase chain reaction validation dataset (<a id="xref-ref-28-2" class="xref-bibr" href="#ref-28">28</a>) assayed only 12 of the 200 genes in the signature, which included, however, well-characterized cancer genes such as <em>APC, RB1</em>, and <em>PDGFRB</em>. The remaining four datasets had less than the 75 samples we required for training (<a id="xref-ref-13-2" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>,<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a>) or were published after our model was finalized (<a id="xref-ref-16-2" class="xref-bibr" href="#ref-16">16</a>). Cutoffs for high and low risk were again determined by calculating the median of the combined patient risk scores in training
                                 data. <strong>F</strong>) Performance in all early-stage, high-grade, serous samples from The Cancer Genome Atlas (TCGA) data. <em>P</em> values were calculated with the log-rank test. All statistical tests were two-sided. <strong>G</strong>) We further tested the model in a dataset in which survival information was only available as binary outcome (long-term vs
                                 short-term survivors) (<a id="xref-ref-19-3" class="xref-bibr" href="#ref-19">19</a>). The prediction model here estimated the probability of short term survival and its accuracy is shown with a receiver operating
                                 characteristic curve. This curve shows the true- and the false-positive rates for all possible cutoffs of the continuous prediction
                                 score. True positives are correctly classified short-term survivors. *Area under the curve (AUC) statistically significantly
                                 greater than 0.5 [DeLong test (<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>)].
                              </p>
                              
                              <div class="sb-div caption-clear"></div>
                           </div>
                        </div>
                        
                        <div id="F4" class="fig pos-float type-figure  odd">
                           <div class="fig-inline"><a href="dju048/F4.expansion.html"><img alt="Figure 4." src="dju048/F4.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                    <li><a href="dju048/F4.expansion.html">In this window</a></li>
                                    <li><a class="in-nw" href="dju048/F4.expansion.html">In a new window</a></li>
                                 </ul>
                                 <ul class="fig-services">
                                    <li class="ppt-link"><a href="/powerpoint/106/5/dju048/F4">Download as PowerPoint Slide</a></li>
                                 </ul>
                              </div>
                           </div>
                           <div class="fig-caption"><span class="fig-label">Figure 4.</span> 
                              
                              <p id="p-24" class="first-child">Combined comparison of our novel meta-analysis gene signature with existing prognostic factors and signatures proposed by
                                 The Cancer Genome Atlas (TCGA). This figure provides a summary view of both leave-one-study-out cross-validation and independent
                                 validation performance shown in <a id="xref-fig-2-3" class="xref-fig" href="#F2">Figures 2</a> and <a id="xref-fig-3-2" class="xref-fig" href="#F3">3</a>. <strong>A</strong>) Summary of the risk stratifications in <a id="xref-fig-2-4" class="xref-fig" href="#F2">Figures 2</a> and <a id="xref-fig-3-3" class="xref-fig" href="#F3">3</a> in a single Kaplan–Meier plot [all studies (Table 1), excluding the TCGA cohort so comparison with the TCGA signatures could
                                 be made (<a id="xref-ref-6-3" class="xref-bibr" href="#ref-6">6</a>,<a id="xref-ref-8-2" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-13-3" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-15-2" class="xref-bibr" href="#ref-15">15</a>,<a id="xref-ref-16-3" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-28-3" class="xref-bibr" href="#ref-28">28–30</a>)]. This plot compares the survival of all patients classified as high risk in this meta-analysis with all low-risk patients.
                                 <strong>B</strong>) Risk stratification based on a fivefold cross-validated multivariable model using the gene signature risk group (high vs
                                 low risk) and the categorical covariables tumor stage (III vs IV) and debulking status (optimal vs suboptimal). The smaller
                                 sample sizes arise because of missing clinical annotations. <strong>C</strong>) Risk stratification based on a fivefold cross-validated multivariable model using tumor stage and debulking status only.
                                 <strong>D</strong>) Summary of risk stratifications by the TCGA gene signature (<a id="xref-ref-9-4" class="xref-bibr" href="#ref-9">9</a>) over all cohorts excluding TCGA, as in panel <strong>A</strong>. <strong>E</strong>) Summary of risk stratifications by the Verhaak et al. survival signature (<a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">18</a>), as in panel <strong>A</strong>. <strong>F</strong>) Summary of risk stratifications by the multivariable model proposed by Verhaak et al. using their survival signature, continuous
                                 TCGA subtype scores, as well as categorical debulking status and tumor stage. <em>P</em> values were calculated with the log-rank test. <strong>G</strong>) Forest plot providing an alternative visualization of the hazard ratios (HRs) shown in the Kaplan–Meier plots <strong>in</strong>
                                 <a id="xref-fig-2-5" class="xref-fig" href="#F2">Figures 2</a>
                                 <strong>and</strong>
                                 <a id="xref-fig-3-4" class="xref-fig" href="#F3">3</a> and including a comparison with the corresponding hazard ratios of the TCGA and Verhaak et al. models in all datasets separately.
                                 <strong>Squares</strong> show hazard ratio point estimates, with size corresponding to their weighting in the fixed-effects meta-analysis summaries
                                 (inverse of squared standard error); <strong>horizontal lines</strong> show 95% confidence intervals (CIs); and <strong>diamonds</strong> at the bottom show fixed-effects summaries of the hazard ratios over all shown datasets. Note that this fixed-effects summary
                                 corresponds to the hazard ratios shown in the summary Kaplan–Meier plots in panels <strong>A</strong>, <strong>D,</strong> and <strong>E</strong>. All statistical tests were two-sided.
                              </p>
                              
                              <div class="sb-div caption-clear"></div>
                           </div>
                        </div>
                        
                        <div id="F5" class="fig pos-float type-figure  odd">
                           <div class="fig-inline"><a href="dju048/F5.expansion.html"><img alt="Figure 6." src="dju048/F5.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                    <li><a href="dju048/F5.expansion.html">In this window</a></li>
                                    <li><a class="in-nw" href="dju048/F5.expansion.html">In a new window</a></li>
                                 </ul>
                                 <ul class="fig-services">
                                    <li class="ppt-link"><a href="/powerpoint/106/5/dju048/F5">Download as PowerPoint Slide</a></li>
                                 </ul>
                              </div>
                           </div>
                           <div class="fig-caption"><span class="fig-label">Figure 6.</span> 
                              
                              <p id="p-25" class="first-child">Validation of selected genes associated with debulking status by quantitative reverse-transcription polymerase chain reaction
                                 (qRT-PCR) in the Bonome et al. validation data (n = 78). <strong>A</strong>) Observed fold-changes in suboptimal vs optimal tumors and their standard deviations of the genes with statistically significantly
                                 (<em>P</em> &lt; .05, two-sided Student <em>t</em> test) different expression between the two groups. <strong>B</strong>) The prediction accuracy of a multivariable model in which the qRT-PCR–validated genes were equally weighted. We stratified
                                 the samples into groups of high and low risk for suboptimal surgery based on the tertiles of the multivariable risk score:
                                 the 33% of patients with highest risk score were classified as high risk, the 33% with lowest risk score were classified as
                                 low risk, and all others were classified as medium risk. Between the high- and low-risk groups, 76.9% of samples were classified
                                 correctly. The accuracy of the multivariable risk prediction is further shown with a receiver operating characteristic curve.
                                 *Area under the curve (AUC) significantly greater than 0.5 [DeLong test (<a id="xref-ref-23-2" class="xref-bibr" href="#ref-23">23</a>)].
                              </p>
                              
                              <div class="sb-div caption-clear"></div>
                           </div>
                        </div>
                        
                        <div id="F6" class="fig pos-float type-figure  odd">
                           <div class="fig-inline"><a href="dju048/F6.expansion.html"><img alt="Figure 7." src="dju048/F6.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                    <li><a href="dju048/F6.expansion.html">In this window</a></li>
                                    <li><a class="in-nw" href="dju048/F6.expansion.html">In a new window</a></li>
                                 </ul>
                                 <ul class="fig-services">
                                    <li class="ppt-link"><a href="/powerpoint/106/5/dju048/F6">Download as PowerPoint Slide</a></li>
                                 </ul>
                              </div>
                           </div>
                           <div class="fig-caption"><span class="fig-label">Figure 7.</span> 
                              
                              <p id="p-26" class="first-child">Validation of POSTN, pSmad2/3, and CXCL14 in an independent cohort by immunohistochemistry (IHC). <strong>A</strong>–<strong>C</strong>) IHC staining of POSTN, pSmad2/3, and CXCL14. The four IHC classes are categorized by IHC intensity scores as described in
                                 the Supplementary Information (available online) and previously (<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>). Scale bar = 100 μm. <strong>D</strong>) Histogram visualizing the frequency of optimal and suboptimal tumors stratified by POSTN IHC class (<strong>A</strong>) in an independent cohort of 177 samples. The true- and false-positive rates of POSTN IHC intensity scores (<a id="xref-ref-27-2" class="xref-bibr" href="#ref-27">27</a>) used for classification are further shown with a receiver operating characteristic curve. <strong>E</strong> and <strong>F</strong>) Corresponding figures for pSmad2/3 and CXCL14. <strong>G</strong>) The prediction accuracy of the multivariable model in which the three IHC validated genes were equally weighted (as in <a id="xref-fig-5-2" class="xref-fig" href="#F5">Figure 6B</a>). * Area under the curve (AUC) statistically significantly greater than 0.5 [DeLong test (<a id="xref-ref-23-3" class="xref-bibr" href="#ref-23">23</a>)].
                              </p>
                              
                              <div class="sb-div caption-clear"></div>
                           </div>
                        </div>
                        
                     </div>
                     
                     <div id="sec-10" class="subsection">
                        
                        <h4>Model Training.</h4>
                        
                        <p id="p-27">We aimed to identify robust prognosis genes for which variation in expression was consistently associated with survival. We
                           first calculated the univariable Cox regression coefficients and their standard errors for each gene in each training dataset.
                           We then summarized the Cox coefficients of gene <em>i</em> across training datasets into a single coefficient <em>β</em>
                           <sub><em>i</em></sub> by a fixed effects meta-analysis (<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>) with coefficients weighted by the inverse of their squared standard errors. We then ranked genes by <em>P</em> value against the null hypothesis that the pooled coefficient is 0. We also compared our results to pooling using a random-effects
                           meta-analysis (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>) (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 2</a>, available online).
                        </p>
                        
                        <p id="p-28" class="indent">We chose a signature size <em>m</em> of 200 genes for all models, a size sufficiently small to be practically useful in a clinical test and sufficiently large
                           to provide robustness in prediction accuracy across technologies. In general, the size of the gene signature had only a modest
                           impact on the prediction accuracy in our algorithm as long as the signature included at least 100 genes (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 3</a>, available online). The <em>m</em> top-ranked genes were used to calculate a risk score for patient <em>j</em>, <em>r</em>
                           <sub><em>j</em></sub>, using our multistudy variant of the compound covariable score (<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>). In this approach, the expression of gene <em>i</em> in subject <em>j, x</em>
                           <sub><em>ij</em></sub>, is weighted by the pooled Cox coefficient of gene <em>i</em> (<em>β</em>
                           <sub><em>i</em></sub>) to calculate the risk score r<sub>j</sub>:
                        </p>
                        <span class="disp-formula" id="disp-formula-1"><span class="mathjax mml-math"><code class="mathjax-code">&lt;mml:math display="block"&gt;&lt;mml:mrow&gt;&lt;mml:msub&gt;&lt;mml:mi&gt;r&lt;/mml:mi&gt;&lt;mml:mi&gt;j&lt;/mml:mi&gt;&lt;/mml:msub&gt;&lt;mml:mo&gt;=&lt;/mml:mo&gt;&lt;mml:mstyle
                                 displaystyle="true"&gt;&lt;mml:munderover&gt;&lt;mml:mo&gt;∑&lt;/mml:mo&gt;&lt;mml:mrow&gt;&lt;mml:mi&gt;i&lt;/mml:mi&gt;&lt;mml:mo&gt;=&lt;/mml:mo&gt;&lt;mml:mn&gt;1&lt;/mml:mn&gt;&lt;/mml:mrow&gt;&lt;mml:mi&gt;m&lt;/mml:mi&gt;&lt;/mml:munderover&gt;&lt;mml:mrow&gt;&lt;mml:msub&gt;&lt;mml:mi&gt;β&lt;/mml:mi&gt;&lt;mml:mi&gt;i&lt;/mml:mi&gt;&lt;/mml:msub&gt;&lt;mml:msub&gt;&lt;mml:mi&gt;x&lt;/mml:mi&gt;&lt;mml:mrow&gt;&lt;mml:mi&gt;i&lt;/mml:mi&gt;&lt;mml:mi&gt;j&lt;/mml:mi&gt;&lt;/mml:mrow&gt;&lt;/mml:msub&gt;&lt;/mml:mrow&gt;&lt;/mml:mstyle&gt;&lt;/mml:mrow&gt;&lt;/mml:math&gt;</code><span class="mathjax-text">rj=∑i=1mβixij</span></span>
                           
                           </span>
                        
                        <p id="p-29">To ensure that gene expression measurements are on the same scale across studies, all gene-specific expression vectors were
                           centered to zero mean and scaled to unit variance within datasets. For binary classification (optimal vs suboptimal debulking),
                           we proceeded analogously, pooling coefficients of a univariable logistic regression model for each gene.
                        </p>
                        
                     </div>
                     
                     <div id="sec-11" class="subsection">
                        
                        <h4>Validation Metrics.</h4>
                        
                        <p id="p-30">Gene signatures were evaluated by hazard ratio (HR) of dichotomized patient risk scores. Dichotomization cutoffs were the
                           medians of these risk scores in the combined training cohorts. Significance of hazard ratio differences between signatures
                           was estimated by bootstrap. Binary outcome classifiers were evaluated by area under the receiver operating characteristic
                           (ROC) curve (or C-index) and the DeLong test (<a id="xref-ref-23-4" class="xref-bibr" href="#ref-23">23</a>). The C-index for censored data was calculated with the survC1 package (<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>), as previously described (<a id="xref-ref-17-3" class="xref-bibr" href="#ref-17">17</a>).
                        </p>
                        
                     </div>
                     
                     <div id="sec-12" class="subsection">
                        
                        <h4>Multivariable Models.</h4>
                        
                        <p id="p-31">To separately assess the added value of clinical variables, we used multivariable models incorporating the gene signature
                           risk group as a categorical covariable (high vs low risk). These only were evaluated by fivefold cross-validation for a Kaplan–Meier
                           analysis. We further assessed the improvement by a likelihood ratio test.
                        </p>
                        
                        <p id="p-32" class="indent">Details of our implementations of published models (<a id="xref-ref-9-5" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-18-3" class="xref-bibr" href="#ref-18">18</a>,<a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>) are given in the Supplementary Methods (available online). <em>P</em> values less than .05 were considered significant. All statistical tests were two-sided.
                        </p>
                        
                     </div>
                     
                  </div>
                  
                  <div id="sec-13" class="subsection">
                     
                     <h3>Quantitative RT-PCR</h3>
                     
                     <p id="p-33">Quantitative RT-PCR was performed as previously described (<a id="xref-ref-13-4" class="xref-bibr" href="#ref-13">13</a>) on 20-ng amplified RNA from 39 suboptimally and 39 optimally debulked specimens selected randomly from the Bonome et al.
                        cohort (<a id="xref-ref-8-3" class="xref-bibr" href="#ref-8">8</a>) that had not been used in model training. Because tumor stage is associated with debulking status (<a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>), numbers of stage III and IV patients (n = 31 and 8, respectively) in the optimal and suboptimal groups were balanced to
                        disassociate stage and debulking status in the qRT-PCR validation cohort. Primer sets were selected (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Table 1</a>, available online) for housekeeping genes <em>GAPDH</em>, <em>GUSB</em>, and <em>ACTB</em> and seven genes showing highly differentiated expression levels through the meta-analysis.
                     </p>
                     
                  </div>
                  
                  <div id="sec-14" class="subsection">
                     
                     <h3>Immunohistochemistry</h3>
                     
                     <p id="p-34">Immunohistochemical staining of POSTN (1.25 μg/mL; BioVendor R&amp;D, Asheville, NC), CXCL14 (ab46010, 2.5 μg/mL; Abcam, Cambridge,
                        UK) and pSmad2/3 (No. 3101, recognizing only phosphorylated Smad2 or Smad3 by transforming growth factor β (TGF-β) receptor,
                        1:200; Cell Signaling, Danvers, MA) was done on an independent validation tissue microarray consisting of 216 stage III/IV,
                        high-grade, serous ovarian cancers obtained from patients with informed consent at the Massachusetts General Hospital (between
                        1993 and 2009. Debulking status was available for 179 cancers (n = 136 optimal and 43 suboptimal). Deparaffinized sections
                        were subjected to antigen retrieval (citrate buffer, pH = 6.1, 95 °C for 30 minutes), incubated with each primary antibody
                        at room temperature for 45 minutes, visualized with ImmPRESS Peroxidase Polymer Detection Reagents (Vector Laboratories, Burlingame,
                        CA) and 3,3’-diaminobenzidine, and counterstained with Mayer’s hematoxylin. Intensity scores were calculated as the average
                        difference in staining intensity between the tumor and stroma areas (<a id="xref-ref-27-3" class="xref-bibr" href="#ref-27">27</a>).
                     </p>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-15">
                  <div class="section-nav"><a href="#sec-5" title="Methods" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-21" title="Discussion" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Results</h2>
                  
                  <p id="p-35">We applied a meta-analytic signature development approach to publicly available high-grade, advanced-stage, serous ovarian
                     cancer microarray gene expression profiles (<a id="xref-table-wrap-1-2" class="xref-table" href="#T1">Table 1</a>) (<a id="xref-ref-5-5" class="xref-bibr" href="#ref-5">5</a>). This included the training and validation of two separate prognostic signatures: the first to identify long- and short-term
                     survivors among patients with early-stage and late-stage, serous ovarian cancer; the second to identify advanced-stage, serous
                     tumors that cannot be optimally debulked to 1cm or less of residual tumor.
                  </p>
                  
                  <div id="sec-16" class="subsection">
                     
                     <h3>Development of an Overall Survival Gene Signature</h3>
                     
                     <p id="p-36">We created a new gene signature consisting of genes whose expression displayed the most statistically significant association
                        with overall survival across major public datasets (<a id="xref-fig-1-2" class="xref-fig" href="#F1">Figure 1</a>). We first used a cross-study validation approach (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 1</a>, available online) to quantify the extent to which our training approach would generate a signature that is consistent across
                        studies. After applying our leave-one-dataset-out cross-validation to the training datasets, we found patients classified
                        as high risk to consistently have significantly shorter survival than low-risk patients (<a id="xref-fig-2-6" class="xref-fig" href="#F2">Figure 2</a>).
                     </p>
                     
                     <p id="p-37" class="indent">We then retrained the signature (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Table 1</a>, available online) using all six training datasets and performed an external validation in seven additional independent datasets.
                        These included a qRT-PCR dataset (<a id="xref-ref-28-4" class="xref-bibr" href="#ref-28">28</a>), three datasets not passing our minimum training sample size of 75 (<a id="xref-ref-13-5" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-29-2" class="xref-bibr" href="#ref-29">29</a>,<a id="xref-ref-30-2" class="xref-bibr" href="#ref-30">30</a>), a dataset that became available after the model was finalized (<a id="xref-ref-16-4" class="xref-bibr" href="#ref-16">16</a>), the TCGA early-stage, high-grade samples (<a id="xref-ref-9-6" class="xref-bibr" href="#ref-9">9</a>), and a dataset for which survival was annotated with a binary label rather than time to death (<a id="xref-ref-19-4" class="xref-bibr" href="#ref-19">19</a>). Our model continued to discriminate short-term from long-term survivors in all of these datasets, as shown by Kaplan–Meier
                        analysis and ROC plots (<a id="xref-fig-3-5" class="xref-fig" href="#F3">Figure 3</a>).
                     </p>
                     
                  </div>
                  
                  <div id="sec-17" class="subsection">
                     
                     <h3>Comparison of the Survival Signature With Existing Prognostic Factors and Gene Signatures</h3>
                     
                     <p id="p-38">We compared Kaplan–Meier stratifications based on our signature to those based on clinical prognostic factors, the original
                        TCGA gene signature (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 4</a>, available online) (<a id="xref-ref-9-7" class="xref-bibr" href="#ref-9">9</a>), which we recently identified as the best performing signature published before July 2012 (<a id="xref-ref-6-4" class="xref-bibr" href="#ref-6">6</a>), and a more recent TCGA signature developed by the same investigators (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figures 5</a> and <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">6</a>, available online) (<a id="xref-ref-18-4" class="xref-bibr" href="#ref-18">18</a>). Clinical prognostic factors include optimal debulking (<a id="xref-ref-8-4" class="xref-bibr" href="#ref-8">8</a>), age, and tumor stage at diagnosis. Only four datasets provided all three factors; however, seven provided both stage and
                        debulking status (<a id="xref-table-wrap-1-3" class="xref-table" href="#T1">Table 1</a>; <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Table 2</a>, available online). We thus focused on these two factors.
                     </p>
                     
                     <p id="p-39" class="indent">When combining the results of cross-study validation and independent validation into a single summary (<a id="xref-fig-4-2" class="xref-fig" href="#F4">Figure 4</a>), patient stratification using our signature was superior to clinical factors, as well as to both of the TCGA gene signatures.
                        Over all cohorts excluding TCGA (n = 1031 patients where direct comparison with the TCGA signatures could be made), patients
                        classified as high risk by our signature had a median survival of 29.6 months (95% confidence interval [CI] = 27.5 to 32.6)
                        compared with 60.1 months (95% CI = 53.2 to 68.0) for the low-risk patients. Our signature (HR = 2.19; 95% CI = 1.84 to 2.61)
                        (<a id="xref-fig-4-3" class="xref-fig" href="#F4">Figure 4A</a>) provided an overall increase in hazard ratio of 0.36 (95% CI = −0.04 to 0.81; <em>P</em> = .04) compared with the original TCGA signature (HR = 1.83, 95% CI = 1.54 to 2.17) (<a id="xref-fig-4-4" class="xref-fig" href="#F4">Figure 4D</a>). Including stage and debulking status in the prediction model provided only a small improvement over our gene signature
                        alone (<em>P</em> = .02, likelihood ratio test) (<a id="xref-fig-4-5" class="xref-fig" href="#F4">Figure 4B</a>). The two signatures proposed by the TCGA consortium performed very similarly compared with each other (HR difference = 0.00;
                        95% CI = −0.33 to 0.34) (<a id="xref-fig-4-6" class="xref-fig" href="#F4">Figure 4</a>, <a id="xref-fig-4-7" class="xref-fig" href="#F4">D</a> and <a id="xref-fig-4-8" class="xref-fig" href="#F4">E</a>; <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 7</a>, available online). The C-index of our signature improved moderately (0.011; 95% CI = −0.015 to 0.037) to 0.62 compared with
                        the TCGA signature. By simulation, we estimated that an additional hazard ratio improvement of 0.27 would be needed to reach
                        statistical significance on the C-index scale as well (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Results</a>, available online). Pathway analysis of our signature showed enrichment of TGF-β and PDGF signaling in poor-prognosis patients
                        (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 8</a>, available online). We finally verified that our meta-analysis training method is superior to single-study training (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 9</a>, available online).
                     </p>
                     
                  </div>
                  
                  <div id="sec-18" class="subsection">
                     
                     <h3>Development of a Gene Signature for Predicting Suboptimal Debulking Surgery</h3>
                     
                     <p id="p-40">Using the same meta-analytic signature development approach, we developed a gene signature for predicting unsuccessful debulking
                        surgery (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Table 1</a>, available online). We expected this signature to differ from the survival signature because the biological basis for optimal
                        surgical removal of tumor tissue is not necessarily the same as that for patient survival. We used all eight late-stage microarray
                        datasets with available debulking information (<a id="xref-table-wrap-1-4" class="xref-table" href="#T1">Table 1</a>), excluding half of the Bonome et al. samples (n = 78) for validation by qRT-PCR.
                     </p>
                     
                     <p id="p-41" class="indent">We first tested our training datasets approach by leave-one-dataset-out validation. Accurate prediction of debulking status
                        proved to be difficult, with an overall area under the curve of 0.59 (95% CI = 0.55 to 0.63) (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 10</a>, available online). In the same data, the signature published by Berchuck et al. (<a id="xref-ref-25-2" class="xref-bibr" href="#ref-25">25</a>) achieved an area under the curve of 0.54 (95% CI = 0.49 to 0.58) (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 11</a> and <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Table 3</a>, available online). Expression of the top-ranked hit POSTN alone achieved prediction accuracies very similar to our signature
                        (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 12</a>, available online). In the 1109 microarray samples with both debulking and survival information, high POSTN levels were prognostic
                        of survival after adjusting for debulking status (<em>P</em> = .04; unadjusted <em>P</em> &lt; .001). The prediction accuracy was robust to the choice of model training parameters (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figures 13</a> and <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">14</a>, available online).
                     </p>
                     
                  </div>
                  
                  <div id="sec-19" class="subsection">
                     
                     <h3>Analysis of Pathways Contributing to Suboptimal Cytoreductive Surgery</h3>
                     
                     <p id="p-42">To explore the molecular basis underlying our debulking signature, we analyzed the gene signature to identify biological pathways
                        relevant to suboptimal disease. Application of pathway identification software (Pathway studio 7.1; Ariadne Genomics, Rockville,
                        MD) identified the hyperactivation of TGF-β/Smad signaling (pathway enrichment analysis, <em>P</em> = .004) and the potential activation of RTK/Ras/MAPK/Egr-1, AMPK/Egr-1, and Hedgehog/Gli signaling in suboptimally debulked
                        tumors (<a id="xref-fig-7-1" class="xref-fig" href="#F7">Figure 5</a>). The resultant transcriptional network leads to upregulation of genes that support tumor dissemination, which decrease the
                        chance of total surgical removal, reducing the possibility of optimal debulking. Potential molecular events responsible for
                        suboptimal surgical outcome involve migration and invasion (<em>MMP2</em>, <em>PLAU</em>, <em>SERPINE1</em>, <em>TIMP3</em>, <em>POSTN</em>, <em>VCAN</em>, <em>FN1</em>, <em>TGFBI</em>, <em>SPARC</em>, and <em>CYR61</em>) (<a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31–38</a>), angiogenesis (<em>EGR1</em>, <em>SMADs</em>, <em>GLIs</em>, <em>VCAN</em>, <em>POSTN</em>, <em>CNY61</em>, and <em>LOX</em>) (<a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">39–45</a>), metastatic colonization (<em>POSTN</em>, <em>VCAN</em>, and <em>LOX</em>) (<a id="xref-ref-46-1" class="xref-bibr" href="#ref-46">46–48</a>), and the activation of tumor-associated fibroblasts (<em>ACTA2</em> and <em>FAP</em>), which play important roles in modulating the tumor microenvironment through the secretion of growth factors and extracellular
                        matrix remodeling to support tumor dissemination through metastasis and angiogenesis (<a id="xref-ref-49-1" class="xref-bibr" href="#ref-49">49</a>,<a id="xref-ref-50-1" class="xref-bibr" href="#ref-50">50</a>).
                     </p>
                     
                     <div id="F7" class="fig pos-float type-figure  odd">
                        <div class="fig-inline"><a href="dju048/F7.expansion.html"><img alt="Figure 5." src="dju048/F7.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="dju048/F7.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="dju048/F7.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/106/5/dju048/F7">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 5.</span> 
                           
                           <p id="p-43" class="first-child">Pathway analysis of the debulking signature. Using the Pathway Studio 7.1 (Ariadne Genomics) software and a novel signature
                              of 200 debulking-associated genes, we identified pathways statistically significantly associated with suboptimal debulking
                              surgery. A gene is labeled in <strong>red</strong> when it is overexpressed in tumors that were subsequently suboptimally debulked. Conversely, genes overexpressed in tumors
                              with optimal cytoreduction are labeled in <strong>blue</strong>. Genes with predictive power toward poor prognosis based on the meta-analysis are highlighted with <strong>pink borders</strong>. <strong>Red broken arrows</strong> indicate direct stimulatory modification. <strong>Green arrows</strong> indicate EGR-1–based transcriptional regulations. <strong>Orange arrows</strong> indicate TGF-β/Smad–based transcriptional regulations. <strong>Blue solid arrows</strong> indicate other direct regulations. <strong>Blue broken arrows</strong> indicate other indirect regulations. <strong>Purple sticks</strong> indicate binding.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                  </div>
                  
                  <div id="sec-20" class="subsection">
                     
                     <h3>Validation of the Debulking Signature by qRT-PCR and Immunohistochemistry in Two Independent Cohorts</h3>
                     
                     <p id="p-44">Within our debulking signature, we selected seven highly differentially expressed genes with known biological role in ovarian
                        tumorigenesis (six genes enriched in the pathway shown in <a id="xref-fig-7-2" class="xref-fig" href="#F7">Figure 5</a>) and validated their expression level by qRT-PCR in an independent cohort of stage III and IV tumors consisting of 78 samples
                        from Bonome et al. (<a id="xref-ref-8-5" class="xref-bibr" href="#ref-8">8</a>), which we had excluded from the meta-analysis for this purpose. Of the seven genes tested, six were statistically significantly
                        associated with surgery outcome (<em>POSTN</em>: <em>P</em> = .03; <em>CXCL14</em>: <em>P</em> = .03; <em>FAP</em>: <em>P</em> = .01; <em>NUAK1</em>: <em>P</em> = .03; <em>PTCH1</em>: <em>P</em> = .004; <em>TGFBR2</em>: <em>P</em> = .005; <em>TNFAIP6</em>: <em>P</em> = .95; all Student <em>t</em> test) (<a id="xref-fig-5-3" class="xref-fig" href="#F5">Figure 6A</a>). A model using all genes classified 76.9% of all samples correctly, with an area under the curve of 0.76 (95% CI = 0.66
                        to 0.87) (<a id="xref-fig-5-4" class="xref-fig" href="#F5">Figure 6B</a>). Using normalized microarray data for the same set of patients, however, only achieved an area under the curve of 0.65 (95%
                        CI = 0.53 to 0.77) through the same model, possibly because of the higher quantitative accuracy of qRT-PCR over microarray.
                        The area under the curve for POSTN qRT-PCR–measured expression level alone was 0.65 (95% CI = 0.53 to 0.77). Furthermore protein
                        expression of three of these proteins, POSTN, CXCL14 (signature genes), and pSmad2/3 (a surrogate marker of TGF-β pathway
                        activation, a signature pathway), was validated by immunohistochemistry in an independent cohort of 179 patients. This analysis
                        confirmed strong association of their expression with debulking status (<a id="xref-fig-6-2" class="xref-fig" href="#F6">Figure 7</a>; <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Table 4</a>, available online). The sum of immunohistochemistry intensities for these three proteins provided a tool that classified
                        92.8% of samples in the high- and low-risk groups for suboptimal debulking correctly, with an area under the curve of 0.89
                        (95% CI = 0.84 to 0.93) (<a id="xref-fig-6-3" class="xref-fig" href="#F6">Figure 7G</a>).
                     </p>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-21">
                  <div class="section-nav"><a href="#sec-15" title="Results" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-22" title="Funding" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Discussion</h2>
                  
                  <p id="p-45">We derived gene expression signatures to predict overall patient survival in early- and late-stage, high-grade, serous ovarian
                     cancer and separately to predict suboptimal debulking surgery. These signatures were developed using the largest gene expression
                     meta-analysis to date for ovarian cancer, incorporating 1525 samples (<a id="xref-fig-1-3" class="xref-fig" href="#F1">Figure 1</a>). This analysis triples the sample size of the largest previous study (<a id="xref-ref-9-8" class="xref-bibr" href="#ref-9">9</a>). Novel signatures were validated (<a id="xref-fig-2-7" class="xref-fig" href="#F2">Figures 2</a>–<a id="xref-fig-6-4" class="xref-fig" href="#F6">7</a>) and shown to provide added value compared with known clinical factors, and they consistently outperformed available gene
                     signatures (<a id="xref-ref-9-9" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-18-5" class="xref-bibr" href="#ref-18">18</a>,<a id="xref-ref-25-3" class="xref-bibr" href="#ref-25">25</a>).
                  </p>
                  
                  <p id="p-46" class="indent">Developing outcome predictors for late-stage cancers has been difficult, in part because of methodologic problems. These include:
                     1) signatures generated on relatively small sample sizes (<a id="xref-ref-51-1" class="xref-bibr" href="#ref-51">51–55</a>); 2) a lack of independent validation (<a id="xref-ref-53-1" class="xref-bibr" href="#ref-53">53</a>,<a id="xref-ref-55-1" class="xref-bibr" href="#ref-55">55</a>); 3) unaudited and unreliable clinical annotation (<a id="xref-ref-53-2" class="xref-bibr" href="#ref-53">53</a>,<a id="xref-ref-56-1" class="xref-bibr" href="#ref-56">56</a>,<a id="xref-ref-57-1" class="xref-bibr" href="#ref-57">57</a>); 4) laboratory-specific biases such as batch effects (<a id="xref-ref-57-2" class="xref-bibr" href="#ref-57">57</a>,<a id="xref-ref-58-1" class="xref-bibr" href="#ref-58">58</a>); and 5) training performed on nonrepresentative patient cohorts (<a id="xref-ref-59-1" class="xref-bibr" href="#ref-59">59</a>). Our comprehensive meta-analysis moves in the direction of addressing these previously missing elements. We trained and
                     validated our models on a large number of carefully curated datasets and used a robust meta-analysis framework that limited
                     the impact of laboratory or cohort-specific biases. Further gains in accuracy will be necessary, and we propose two ways these
                     gains may be made: 1) larger sample size studies and 2) increased standardization and rigor of study design and clinical annotations.
                     Prediction accuracy in validation datasets often shows an increasing trend with training sample size, even up to 1250 samples
                     (<a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/dju048/-/DC1">Supplementary Figure 9</a>, available online). This continual increase is striking, considering the heterogeneous surgical and medical management used
                     by the different hospitals represented in this meta-analysis. Such heterogeneity highlights the limitations of signatures
                     developed from any single institution and the need for specimens from clinical trials with precisely specified inclusion criteria.
                  </p>
                  
                  <p id="p-47" class="indent">Successful outcome predictors for ovarian cancer are particularly challenging because of the current gap between discrimination
                     ability and clinical utility. Clinical utility is defined on whether the results provide substantial prognostic or predictive
                     information as to alter patient management or behavior in ways that ultimately improve outcomes. It is important to note that
                     the vast majority of advanced-stage ovarian cancer patients initially respond to standard treatment but then suffer recurrence
                     and ultimately die of their disease. As such, we estimate that for a survival signature to be clinically relevant in this
                     patient population, it would have to identify patients with refractory disease (progressive or persistent disease during primary
                     therapy). These patients have a median survival of 9 months. If such a sufficiently accurate signature were identified, one
                     could triage the poor-prognosis patients to phase II trials to attempt to identify active agents against these tumors at the
                     first attempt. The survival signature we generated here, although significantly improved over published signatures, does not
                     meet this standard [for a discussion of the relatively low C-indices of our and published signatures, see (<a id="xref-ref-17-4" class="xref-bibr" href="#ref-17">17</a>)]. Although the poor-prognostic patients have a shorter survival, most clearly respond to and benefit from standard combination
                     chemotherapy. Thus, this signature would not alter clinical management of advanced-stage patients. Of interest, although our
                     survival signature was established entirely from late-stage, serous tumors, it demonstrated considerable promise for stratifying
                     early-stage, high-grade, serous tumors. This finding may reflect the underlying biology of recurrent early-stage ovarian cancer
                     because these tumors have gene expression profiles similar to poor-prognosis, advanced-stage cancers. A reliable stratification
                     of early-stage patients could spare low-risk patients unnecessary adjuvant chemotherapy. Unfortunately, our signature is preliminary
                     in this patient group and will require validation in a much larger set of specimens. Our results suggest that meta-analyses
                     like ours can help in achieving adequate sample sizes to establish genomic signatures with clinical utility.
                  </p>
                  
                  <p id="p-48" class="indent">In contrast, the debulking signature will have clinical utility if the 93% accuracy of the immunohistochemistry tool observed
                     in our 179-patient validation cohort is confirmed in prospective validation. Cytoreductive surgery remains an important component
                     of treatment for women with epithelial ovarian cancer (<a id="xref-ref-8-6" class="xref-bibr" href="#ref-8">8</a>). Whether this fact is due to 1) the smaller residual tumor mass or 2) an intrinsic biological element of tumors, providing
                     less aggressive and invasive tumors an advantage in surgery, remains unresolved (<a id="xref-ref-26-2" class="xref-bibr" href="#ref-26">26</a>). We present the strongest evidence to date for the existence of a biologic basis and a predictive gene signature for debulking
                     ability of ovarian tumors. The immunohistochemistry staining showed high predictive values of our identified biomarkers. It
                     is interesting to note that of the top five misclassified optimal cases (high protein expression for all three biomarkers),
                     two were wrongly annotated and had 1-cm residual disease. This suggests that the signature may be even more accurate than
                     we report, and its limitation is dependent in part on the clinical classification of degree of debulking. The clinical utility
                     in this case results from the identification of those patients who will not benefit from primary debulking surgery, sparing
                     them the toxicity of extensive surgery and the delay until the initiation of chemotherapy. These patients can be triaged to
                     neoadjuvant chemotherapy with interval debulking. An European Organisation for Research and Treatment of Cancer study has
                     recently demonstrated that neoadjuvant therapy with interval debulking is equivalent to primary debulking and adjuvant chemotherapy
                     (<a id="xref-ref-60-1" class="xref-bibr" href="#ref-60">60</a>). A genomic tool of this nature will assist surgeons in stratifying patients for these alternative approaches.
                  </p>
                  
                  <p id="p-49" class="indent">The debulking signature also provides biologic insight into ovarian cancer dissemination. TGF-β pathway activation has been
                     documented in ovarian cancer with tumors becoming resistant to the growth inhibitory effects of the ligand (<a id="xref-ref-61-1" class="xref-bibr" href="#ref-61">61</a>,<a id="xref-ref-62-1" class="xref-bibr" href="#ref-62">62</a>). These data suggest that in a subset of tumors, the TGF-β activated pathway stimulates epithelial-mesenchymal transition,
                     the activation of tumor associated fibroblasts, and other biologic processes that contribute to spread of the tumor with resultant
                     difficulty in surgical debulking. These pathways may also provide therapeutic targets to convert tumors that are not resectable
                     in the neoadjuvant setting to ones that are at interval debulking.
                  </p>
                  
               </div>
               <div class="section" id="sec-22">
                  <div class="section-nav"><a href="#sec-21" title="Discussion" class="prev-section-link"><span>Previous Section</span></a><a href="#notes-1" title="Notes" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Funding</h2>
                  
                  <p id="p-50">This work was supported by grants from the <span class="funding-source">National Cancer Institute at the National Institutes of Health</span>
                     (<span class="award-id" id="award-id-1">1RC4CA156551-01</span> and <span class="award-id" id="award-id-2">5R01CA142832</span> to MB); the <span class="funding-source">Dana-Farber/Harvard Cancer Center</span>
                     <span class="award-id" id="award-id-3">NCI 5P30 CA006516-46</span> to GP and MB); and the <span class="funding-source">National Science Foundation</span> (<span class="award-id" id="award-id-4">CAREER DBI-1053486</span> to CH).
                  </p>
                  
               </div>
               <div class="section notes" id="notes-1">
                  <div class="section-nav"><a href="#sec-22" title="Funding" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Notes</h2>
                  
                  <p id="p-51">The authors are solely responsible for the design of the study; the collection, analysis, and interpretation of the data;
                     the writing of the manuscript; and the decision to submit the manuscript for publication. There are no other conflicts of
                     interest. All authors read and approved the final article.
                  </p>
                  
                  <p id="p-52">We thank Benjamin Haibe-Kains for comments on the manuscript.</p>
                  
               </div>
               <ul class="copyright-statement">
                  <li class="fn" id="copyright-statement-1">© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</li>
               </ul>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#notes-1" title="Notes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder"> </div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list ref-use-labels">
                     <li><span class="ref-label">1.</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text"
                           id="ref-1">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.1"
                             data-doi="10.3322/caac.20138">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Siegel</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Naishadham</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jemal</span>  <span class="cit-name-given-names">A</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Cancer statistics, 2012</span>.
                                 <abbr class="cit-jnl-abbrev">CA Cancer J Clin</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">62</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">10</span>–<span class="cit-lpage">29</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.3322/caac.20138&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=22237781&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000299800100004&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Cancer%20statistics%2C%202012&amp;author=R%20Siegel&amp;author=D%20Naishadham&amp;author=A%20Jemal&amp;publication_year=2012&amp;journal=CA%20Cancer%20J%20Clin&amp;volume=62&amp;issue=1&amp;pages=10-29">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">2.</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text"
                           id="ref-2">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.2"
                             data-doi="10.1111/IGC.0b013e3181cff38b">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ibeanu</span>  <span class="cit-name-given-names">OA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bristow</span>  <span class="cit-name-given-names">RE</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Predicting the outcome of cytoreductive surgery for advanced ovarian cancer: a review</span>.
                                 <abbr class="cit-jnl-abbrev">Int J Gynecol Cancer</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">20</span>(<span class="cit-supplement">Suppl 1</span>):<span class="cit-fpage">S1</span>–<span class="cit-lpage">S11</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1111/IGC.0b013e3181cff38b&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=20065732&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Predicting%20the%20outcome%20of%20cytoreductive%20surgery%20for%20advanced%20ovarian%20cancer%3A%20a%20review&amp;author=OA%20Ibeanu&amp;author=RE%20Bristow&amp;publication_year=2010&amp;journal=Int%20J%20Gynecol%20Cancer&amp;volume=20&amp;pages=S1-S11">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">3.</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text"
                           id="ref-3">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.3"
                             data-doi="10.1245/s10434-012-2446-8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chang</span>  <span class="cit-name-given-names">SJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bristow</span>  <span class="cit-name-given-names">RE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ryu</span>  <span class="cit-name-given-names">HS</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures
                                    on survival in advanced ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Ann Surg Oncol</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">19</span>(<span class="cit-issue">13</span>):<span class="cit-fpage">4059</span>–<span class="cit-lpage">4067</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1245/s10434-012-2446-8&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=22766983&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000311512400011&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Impact%20of%20complete%20cytoreduction%20leaving%20no%20gross%20residual%20disease%20associated%20with%20radical%20cytoreductive%20surgical%20procedures%20on%20survival%20in%20advanced%20ovarian%20cancer&amp;author=SJ%20Chang&amp;author=RE%20Bristow&amp;author=HS%20Ryu&amp;publication_year=2012&amp;journal=Ann%20Surg%20Oncol&amp;volume=19&amp;issue=13&amp;pages=4059-4067">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">4.</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text"
                           id="ref-4">↵</a>
                        
                        
                        <div class="cit ref-cit ref-book" id="cit-106.5.dju048.4">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Barakat</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Berchuck</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Markman</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-source">Principles and Practice of Gynecologic Oncology</span>.
                                 <span class="cit-edition">6th</span> ed. <span class="cit-publ-loc">Philadelphia, PA</span>: <span class="cit-publ-name">Lippincott Williams &amp; Wilkins</span>; <span class="cit-pub-date">2013</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Principles%20and%20Practice%20of%20Gynecologic%20Oncology&amp;author=R%20Barakat&amp;author=A%20Berchuck&amp;author=M%20Markman&amp;publication_year=2013">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">5.</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text"
                           id="ref-5">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.5">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ganzfried</span>  <span class="cit-name-given-names">BF</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Riester</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Haibe-Kains</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome</span>.
                                 <abbr class="cit-jnl-abbrev">Database (Oxford)</abbr>. doi:10.1093/database/bat013.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=curatedOvarianData%3A%20clinically%20annotated%20data%20for%20the%20ovarian%20cancer%20transcriptome&amp;author=BF%20Ganzfried&amp;author=M%20Riester&amp;author=B%20Haibe-Kains&amp;journal=Database%20%28Oxford%29">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">6.</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text"
                           id="ref-6">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.6">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bentink</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Haibe-Kains</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Risch</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">PLoS One</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">7</span>(<span class="cit-issue">2</span>):e30269. doi:10.1371/journal.pone.0030269.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Angiogenic%20mRNA%20and%20microRNA%20gene%20expression%20signature%20predicts%20a%20novel%20subtype%20of%20serous%20ovarian%20cancer&amp;author=S%20Bentink&amp;author=B%20Haibe-Kains&amp;author=T%20Risch&amp;publication_year=2012&amp;journal=PLoS%20One&amp;volume=7&amp;issue=2">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">7.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.7"
                             data-doi="10.1158/0008-5472.CAN-05-2240">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bonome</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lee</span>  <span class="cit-name-given-names">J-Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Park</span>  <span class="cit-name-given-names">D-C</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary</span>.
                                 <abbr class="cit-jnl-abbrev">Cancer Res</abbr>.
                                 <span class="cit-pub-date">2005</span>;<span class="cit-vol">65</span>(<span class="cit-issue">22</span>):<span class="cit-fpage">10602</span>–<span class="cit-lpage">10612</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=65/22/10602"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">8.</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text"
                           id="ref-8">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.8"
                             data-doi="10.1158/0008-5472.CAN-07-6595">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bonome</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Levine</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shih</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Cancer Res</abbr>.
                                 <span class="cit-pub-date">2008</span>;<span class="cit-vol">68</span>(<span class="cit-issue">13</span>):<span class="cit-fpage">5478</span>–<span class="cit-lpage">5486</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=68/13/5478"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">9.</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text"
                           id="ref-9">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.9"
                             data-doi="10.1038/nature10166">
                           <div class="cit-metadata"><cite><span class="cit-auth cit-collab">Cancer Genome Atlas Research Network</span>.
                                 <span class="cit-article-title">Integrated genomic analyses of ovarian carcinoma</span>.
                                 <abbr class="cit-jnl-abbrev">Nature</abbr>.
                                 <span class="cit-pub-date">2011</span>;<span class="cit-vol">474</span>(<span class="cit-issue">7353</span>):<span class="cit-fpage">609</span>–<span class="cit-lpage">615</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/nature10166&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=21720365&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000292204300032&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">10.</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text"
                           id="ref-10">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.10">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Crijns</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fehrmann</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">de Jong</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Survival-related profile, pathways, and transcription factors in ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">PLoS Med</abbr>.
                                 <span class="cit-pub-date">2009</span>;<span class="cit-vol">6</span>(<span class="cit-issue">2</span>):e24. doi:10.1371/journal.pmed.1000024.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Survival-related%20profile%2C%20pathways%2C%20and%20transcription%20factors%20in%20ovarian%20cancer&amp;author=A%20Crijns&amp;author=R%20Fehrmann&amp;author=S%20de%20Jong&amp;publication_year=2009&amp;journal=PLoS%20Med&amp;volume=6&amp;issue=2">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">11.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.11"
                             data-doi="10.1002/path.2547">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Denkert</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Budczies</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Darb-Esfahani</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">A prognostic gene expression index in ovarian cancer—validation across different independent data sets</span>.
                                 <abbr class="cit-jnl-abbrev">J Pathol</abbr>.
                                 <span class="cit-pub-date">2009</span>;<span class="cit-vol">218</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">273</span>–<span class="cit-lpage">280</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/path.2547&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19294737&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000266338000015&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20prognostic%20gene%20expression%20index%20in%20ovarian%20cancer%E2%80%94validation%20across%20different%20independent%20data%20sets&amp;author=C%20Denkert&amp;author=J%20Budczies&amp;author=S%20Darb-Esfahani&amp;publication_year=2009&amp;journal=J%20Pathol&amp;volume=218&amp;issue=2&amp;pages=273-280">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">12.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.12"
                             data-doi="10.1158/0008-5472.CAN-09-3912">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hernandez</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hsu</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Davidson</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Cancer Res</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">70</span>(<span class="cit-issue">10</span>):<span class="cit-fpage">4005</span>–<span class="cit-lpage">4014</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=70/10/4005"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">13.</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13. in text"
                           id="ref-13">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.13"
                             data-doi="10.1016/j.ccr.2009.10.018">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mok</span>  <span class="cit-name-given-names">SC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bonome</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vathipadiekal</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein
                                    2</span>.
                                 <abbr class="cit-jnl-abbrev">Cancer Cell</abbr>.
                                 <span class="cit-pub-date">2009</span>;<span class="cit-vol">16</span>(<span class="cit-issue">6</span>):<span class="cit-fpage">521</span>–<span class="cit-lpage">532</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ccr.2009.10.018&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19962670&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000272693700011&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20gene%20signature%20predictive%20for%20outcome%20in%20advanced%20ovarian%20cancer%20identifies%20a%20survival%20factor%3A%20microfibril-associated%20glycoprotein%202&amp;author=SC%20Mok&amp;author=T%20Bonome&amp;author=V%20Vathipadiekal&amp;publication_year=2009&amp;journal=Cancer%20Cell&amp;volume=16&amp;issue=6&amp;pages=521-532">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">14.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.14"
                             data-doi="10.1038/bjc.2011.219">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sabatier</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Finetti</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bonensea</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">A seven-gene prognostic model for platinum-treated ovarian carcinomas</span>.
                                 <abbr class="cit-jnl-abbrev">Br J Cancer</abbr>.
                                 <span class="cit-pub-date">2011</span>;<span class="cit-vol">105</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">304</span>–<span class="cit-lpage">311</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/bjc.2011.219&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=21654678&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000292684200016&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20seven-gene%20prognostic%20model%20for%20platinum-treated%20ovarian%20carcinomas&amp;author=R%20Sabatier&amp;author=P%20Finetti&amp;author=J%20Bonensea&amp;publication_year=2011&amp;journal=Br%20J%20Cancer&amp;volume=105&amp;issue=2&amp;pages=304-311">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">15.</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15. in text"
                           id="ref-15">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.15">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yoshihara</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tajima</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yahata</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets</span>.
                                 <abbr class="cit-jnl-abbrev">PLoS One</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">5</span>(<span class="cit-issue">3</span>):e9615. doi:10.1371/journal.pone.0009615.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Gene%20expression%20profile%20for%20predicting%20survival%20in%20advanced-stage%20serous%20ovarian%20cancer%20across%20two%20independent%20datasets&amp;author=K%20Yoshihara&amp;author=A%20Tajima&amp;author=T%20Yahata&amp;publication_year=2010&amp;journal=PLoS%20One&amp;volume=5&amp;issue=3">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">16.</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16. in text"
                           id="ref-16">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.16"
                             data-doi="10.1158/1078-0432.CCR-11-2725">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yoshihara</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tsunoda</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shigemizu</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation
                                    pathway</span>.
                                 <abbr class="cit-jnl-abbrev">Clin Cancer Res</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">18</span>(<span class="cit-issue">5</span>):<span class="cit-fpage">1374</span>–<span class="cit-lpage">1385</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=clincanres&amp;resid=18/5/1374"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">17.</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17. in text"
                           id="ref-17">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-106.5.dju048.17">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Waldron</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Haibe-Kains</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Culhane</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite> A comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer. J Natl Cancer Inst. 2014;.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?author=L%20Waldron&amp;author=B%20Haibe-Kains&amp;author=A%20Culhane">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">18.</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18. in text"
                           id="ref-18">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.18">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Verhaak</span>  <span class="cit-name-given-names">RG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tamayo</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yang</span>  <span class="cit-name-given-names">JY</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Prognostically relevant gene signatures of high-grade serous ovarian carcinoma</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Invest</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">123</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">517</span>–<span class="cit-lpage">525</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=23257362&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000313598500052&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Prognostically%20relevant%20gene%20signatures%20of%20high-grade%20serous%20ovarian%20carcinoma&amp;author=RG%20Verhaak&amp;author=P%20Tamayo&amp;author=JY%20Yang&amp;publication_year=2012&amp;journal=J%20Clin%20Invest&amp;volume=123&amp;issue=1&amp;pages=517-525">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">19.</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19. in text"
                           id="ref-19">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.19"
                             data-doi="10.1016/j.ejca.2006.06.026">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Partheen</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Levan</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Osterberg</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors</span>.
                                 <abbr class="cit-jnl-abbrev">Eur J Cancer</abbr>.
                                 <span class="cit-pub-date">2006</span>;<span class="cit-vol">42</span>(<span class="cit-issue">16</span>):<span class="cit-fpage">2846</span>–<span class="cit-lpage">2854</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ejca.2006.06.026&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16996261&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000242501700036&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Expression%20analysis%20of%20stage%20III%20serous%20ovarian%20adenocarcinoma%20distinguishes%20a%20sub-group%20of%20survivors&amp;author=K%20Partheen&amp;author=K%20Levan&amp;author=L%20Osterberg&amp;publication_year=2006&amp;journal=Eur%20J%20Cancer&amp;volume=42&amp;issue=16&amp;pages=2846-2854">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">20.</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20. in text"
                           id="ref-20">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.20"
                             data-doi="10.1037//1082-989X.3.4.486">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hedges</span>  <span class="cit-name-given-names">LV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vevea</span>  <span class="cit-name-given-names">JL</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Fixed- and random-effects models in meta-analysis</span>.
                                 <abbr class="cit-jnl-abbrev">Psychol Meth</abbr>.
                                 <span class="cit-pub-date">1998</span>;<span class="cit-vol">3</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">486</span>–<span class="cit-lpage">504</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1037//1082-989X.3.4.486&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=000077640200006&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Fixed-%20and%20random-effects%20models%20in%20meta-analysis&amp;author=LV%20Hedges&amp;author=JL%20Vevea&amp;publication_year=1998&amp;journal=Psychol%20Meth&amp;volume=3&amp;issue=4&amp;pages=486-504">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">21.</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21. in text"
                           id="ref-21">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.21"
                             data-doi="10.3102/10769986030003261">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Viechtbauer</span>  <span class="cit-name-given-names">W</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Bias and efficiency of meta-analytic variance estimators in the random-effects model</span>.
                                 <abbr class="cit-jnl-abbrev">J Educ Behav Stat</abbr>.
                                 <span class="cit-pub-date">2005</span>;<span class="cit-vol">30</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">261</span>–<span class="cit-lpage">293</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.3102/10769986030003261&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=000235116400002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Bias%20and%20efficiency%20of%20meta-analytic%20variance%20estimators%20in%20the%20random-effects%20model&amp;author=W%20Viechtbauer&amp;publication_year=2005&amp;journal=J%20Educ%20Behav%20Stat&amp;volume=30&amp;issue=3&amp;pages=261-293">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">22.</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22. in text"
                           id="ref-22">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.22"
                             data-doi="10.1016/0197-2456(93)90225-3">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tukey</span>  <span class="cit-name-given-names">JW</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Tightening the clinical trial</span>.
                                 <abbr class="cit-jnl-abbrev">Control Clin Trials</abbr>.
                                 <span class="cit-pub-date">1993</span>;<span class="cit-vol">14</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">266</span>–<span class="cit-lpage">285</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0197-2456(93)90225-3&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8365193&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1993LQ02000003&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Tightening%20the%20clinical%20trial&amp;author=JW%20Tukey&amp;publication_year=1993&amp;journal=Control%20Clin%20Trials&amp;volume=14&amp;issue=4&amp;pages=266-285">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">23.</span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23. in text"
                           id="ref-23">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.23"
                             data-doi="10.2307/2531595">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">DeLong</span>  <span class="cit-name-given-names">ER</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">DeLong</span>  <span class="cit-name-given-names">DM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clarke-Pearson</span>  <span class="cit-name-given-names">DL</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach</span>.
                                 <abbr class="cit-jnl-abbrev">Biometrics</abbr>.
                                 <span class="cit-pub-date">1988</span>;<span class="cit-vol">44</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">837</span>–<span class="cit-lpage">845</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.2307/2531595&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=3203132&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1988Q069100016&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Comparing%20the%20areas%20under%20two%20or%20more%20correlated%20receiver%20operating%20characteristic%20curves%3A%20a%20nonparametric%20approach&amp;author=ER%20DeLong&amp;author=DM%20DeLong&amp;author=DL%20Clarke-Pearson&amp;publication_year=1988&amp;journal=Biometrics&amp;volume=44&amp;issue=3&amp;pages=837-845">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">24.</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24. in text"
                           id="ref-24">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.24"
                             data-doi="10.1002/sim.4154">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Uno</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cai</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pencina</span>  <span class="cit-name-given-names">MJ</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data</span>.
                                 <abbr class="cit-jnl-abbrev">Stat Med</abbr>.
                                 <span class="cit-pub-date">2011</span>;<span class="cit-vol">30</span>(<span class="cit-issue">10</span>):<span class="cit-fpage">1105</span>–<span class="cit-lpage">1117</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/sim.4154&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=21484848&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=On%20the%20C-statistics%20for%20evaluating%20overall%20adequacy%20of%20risk%20prediction%20procedures%20with%20censored%20survival%20data&amp;author=H%20Uno&amp;author=T%20Cai&amp;author=MJ%20Pencina&amp;publication_year=2011&amp;journal=Stat%20Med&amp;volume=30&amp;issue=10&amp;pages=1105-1117">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">25.</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25. in text"
                           id="ref-25">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.25"
                             data-doi="10.1016/j.ajog.2004.02.005">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Berchuck</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Iversen</span>  <span class="cit-name-given-names">ES</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lancaster</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays</span>.
                                 <abbr class="cit-jnl-abbrev">Am J Obstet Gynecol</abbr>.
                                 <span class="cit-pub-date">2004</span>;<span class="cit-vol">190</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">910</span>–<span class="cit-lpage">925</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ajog.2004.02.005&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15118612&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Prediction%20of%20optimal%20versus%20suboptimal%20cytoreduction%20of%20advanced-stage%20serous%20ovarian%20cancer%20with%20the%20use%20of%20microarrays&amp;author=A%20Berchuck&amp;author=ES%20Iversen&amp;author=JM%20Lancaster&amp;publication_year=2004&amp;journal=Am%20J%20Obstet%20Gynecol&amp;volume=190&amp;issue=4&amp;pages=910-925">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">26.</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26. in text"
                           id="ref-26">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.26"
                             data-doi="10.1038/bjc.2012.376">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Borley</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wilhelm-Benartzi</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Brown</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review</span>.
                                 <abbr class="cit-jnl-abbrev">Br J Cancer</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">107</span>(<span class="cit-issue">7</span>):<span class="cit-fpage">1069</span>–<span class="cit-lpage">1074</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/bjc.2012.376&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=22935582&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000309540800010&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Does%20tumour%20biology%20determine%20surgical%20success%20in%20the%20treatment%20of%20epithelial%20ovarian%20cancer%3F%20A%20systematic%20literature%20review&amp;author=J%20Borley&amp;author=C%20Wilhelm-Benartzi&amp;author=R%20Brown&amp;publication_year=2012&amp;journal=Br%20J%20Cancer&amp;volume=107&amp;issue=7&amp;pages=1069-1074">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">27.</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27. in text"
                           id="ref-27">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.27"
                             data-doi="10.1200/JCO.2006.09.0795">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Birrer</span>  <span class="cit-name-given-names">MJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Johnson</span>  <span class="cit-name-given-names">ME</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hao</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1
                                    as a prognostic marker for advanced-stage serous ovarian adenocarcinomas</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2007</span>;<span class="cit-vol">25</span>(<span class="cit-issue">16</span>):<span class="cit-fpage">2281</span>–<span class="cit-lpage">2287</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=25/16/2281"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">28.</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28. in text"
                           id="ref-28">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.28"
                             data-doi="10.1158/1078-0432.CCR-12-0056">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gillet</span>  <span class="cit-name-given-names">J-P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Calcagno</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Varma</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma</span>.
                                 <abbr class="cit-jnl-abbrev">Clin Cancer Res</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">18</span>(<span class="cit-issue">11</span>):<span class="cit-fpage">3197</span>–<span class="cit-lpage">3206</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=clincanres&amp;resid=18/11/3197"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">29.</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29. in text"
                           id="ref-29">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.29"
                             data-doi="10.1200/JCO.2006.06.3743">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dressman</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Berchuck</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chan</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2007</span>;<span class="cit-vol">25</span>(<span class="cit-issue">5</span>):<span class="cit-fpage">517</span>–<span class="cit-lpage">525</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=25/5/517"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">30.</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30. in text"
                           id="ref-30">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.30"
                             data-doi="10.1200/JCO.2009.27.5719">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Konstantinopoulos</span>  <span class="cit-name-given-names">PA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Spentzos</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Karlan</span>  <span class="cit-name-given-names">BY</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with
                                    epithelial ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">28</span>(<span class="cit-issue">22</span>):<span class="cit-fpage">3555</span>–<span class="cit-lpage">3561</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=28/22/3555"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">31.</span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31. in text"
                           id="ref-31">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.31"
                             data-doi="10.1371/journal.pone.0042413">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chen</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wang</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Xi</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">PLoS One</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">7</span>(<span class="cit-issue">8</span>):<span class="cit-fpage">e42413</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1371/journal.pone.0042413&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=22879971&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=SPARC%20is%20a%20key%20regulator%20of%20proliferation%2C%20apoptosis%20and%20invasion%20in%20human%20ovarian%20cancer&amp;author=J%20Chen&amp;author=M%20Wang&amp;author=B%20Xi&amp;publication_year=2012&amp;journal=PLoS%20One&amp;volume=7&amp;issue=8&amp;pages=e42413">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">32.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.32"
                             data-doi="10.1007/s10555-006-7886-9">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Deryugina</span>  <span class="cit-name-given-names">EI</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Quigley</span>  <span class="cit-name-given-names">JP</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Matrix metalloproteinases and tumor metastasis</span>.
                                 <abbr class="cit-jnl-abbrev">Cancer Metastasis Rev</abbr>.
                                 <span class="cit-pub-date">2006</span>;<span class="cit-vol">25</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">9</span>–<span class="cit-lpage">34</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s10555-006-7886-9&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16680569&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000237359500002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinases%20and%20tumor%20metastasis&amp;author=EI%20Deryugina&amp;author=JP%20Quigley&amp;publication_year=2006&amp;journal=Cancer%20Metastasis%20Rev&amp;volume=25&amp;issue=1&amp;pages=9-34">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">33.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.33"
                             data-doi="10.1038/onc.2010.532">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mitra</span>  <span class="cit-name-given-names">AK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sawada</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tiwari</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis</span>.
                                 <abbr class="cit-jnl-abbrev">Oncogene</abbr>.
                                 <span class="cit-pub-date">2011</span>;<span class="cit-vol">30</span>(<span class="cit-issue">13</span>):<span class="cit-fpage">1566</span>–<span class="cit-lpage">1576</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/onc.2010.532&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=21119598&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000288998300007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Ligand-independent%20activation%20of%20c-Met%20by%20fibronectin%20and%20alpha%285%29beta%281%29-integrin%20regulates%20ovarian%20cancer%20invasion%20and%20metastasis&amp;author=AK%20Mitra&amp;author=K%20Sawada&amp;author=P%20Tiwari&amp;publication_year=2011&amp;journal=Oncogene&amp;volume=30&amp;issue=13&amp;pages=1566-1576">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">34.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.34"
                             data-doi="10.1586/erm.11.47">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schmitt</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Harbeck</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Brunner</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1</span>.
                                 <abbr class="cit-jnl-abbrev">Expert Rev Mol Diagn</abbr>.
                                 <span class="cit-pub-date">2011</span>;<span class="cit-vol">11</span>(<span class="cit-issue">6</span>):<span class="cit-fpage">617</span>–<span class="cit-lpage">634</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1586/erm.11.47&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=21745015&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Cancer%20therapy%20trials%20employing%20level-of-evidence-1%20disease%20forecast%20cancer%20biomarkers%20uPA%20and%20its%20inhibitor%20PAI-1&amp;author=M%20Schmitt&amp;author=N%20Harbeck&amp;author=N%20Brunner&amp;publication_year=2011&amp;journal=Expert%20Rev%20Mol%20Diagn&amp;volume=11&amp;issue=6&amp;pages=617-634">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">35.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.35"
                             data-doi="10.2353/ajpath.2010.090748">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Soikkeli</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Podlasz</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yin</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion,
                                    migration, and growth</span>.
                                 <abbr class="cit-jnl-abbrev">Am J Pathol</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">177</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">387</span>–<span class="cit-lpage">403</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.2353/ajpath.2010.090748&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=20489157&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000279805100040&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Metastatic%20outgrowth%20encompasses%20COL-I%2C%20FN1%2C%20and%20POSTN%20up-regulation%20and%20assembly%20to%20fibrillar%20networks%20regulating%20cell%20adhesion%2C%20migration%2C%20and%20growth&amp;author=J%20Soikkeli&amp;author=P%20Podlasz&amp;author=M%20Yin&amp;publication_year=2010&amp;journal=Am%20J%20Pathol&amp;volume=177&amp;issue=1&amp;pages=387-403">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">36.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.36"
                             data-doi="10.1016/j.biopha.2012.10.003">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tang</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Han</span>  <span class="cit-name-given-names">X</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">The urokinase plasminogen activator system in breast cancer invasion and metastasis</span>.
                                 <abbr class="cit-jnl-abbrev">Biomed Pharmacother</abbr>.
                                 <span class="cit-pub-date">2013</span>;<span class="cit-vol">67</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">179</span>–<span class="cit-lpage">182</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.biopha.2012.10.003&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=23201006&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000317098000013&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=The%20urokinase%20plasminogen%20activator%20system%20in%20breast%20cancer%20invasion%20and%20metastasis&amp;author=L%20Tang&amp;author=X%20Han&amp;publication_year=2013&amp;journal=Biomed%20Pharmacother&amp;volume=67&amp;issue=2&amp;pages=179-182">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">37.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.37"
                             data-doi="10.3390/ijms130810461">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ween</span>  <span class="cit-name-given-names">MP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Oehler</span>  <span class="cit-name-given-names">MK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ricciardelli</span>  <span class="cit-name-given-names">C</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Transforming growth factor-beta-induced protein (TGFBI)/(betaig-H3): a matrix protein with dual functions in ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Int J Mol Sci</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">13</span>(<span class="cit-issue">8</span>):<span class="cit-fpage">10461</span>–<span class="cit-lpage">10477</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.3390/ijms130810461&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=22949874&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Transforming%20growth%20factor-beta-induced%20protein%20%28TGFBI%29%2F%28betaig-H3%29%3A%20a%20matrix%20protein%20with%20dual%20functions%20in%20ovarian%20cancer&amp;author=MP%20Ween&amp;author=MK%20Oehler&amp;author=C%20Ricciardelli&amp;publication_year=2012&amp;journal=Int%20J%20Mol%20Sci&amp;volume=13&amp;issue=8&amp;pages=10461-10477">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">38.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.38"
                             data-doi="10.1158/1538-7445.AM2013-5016">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yeung</span>  <span class="cit-name-given-names">TL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Leung</span>  <span class="cit-name-given-names">CS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wong</span>  <span class="cit-name-given-names">KK</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment</span>.
                                 <abbr class="cit-jnl-abbrev">Cancer Res</abbr>.
                                 <span class="cit-pub-date">2013</span>;<span class="cit-vol">73</span>(<span class="cit-issue">16</span>):<span class="cit-fpage">5016</span>–<span class="cit-lpage">5028</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1158/1538-7445.AM2013-5016&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=23824740&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000323161800007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=TGF-beta%20modulates%20ovarian%20cancer%20invasion%20by%20upregulating%20CAF-derived%20versican%20in%20the%20tumor%20microenvironment&amp;author=TL%20Yeung&amp;author=CS%20Leung&amp;author=KK%20Wong&amp;publication_year=2013&amp;journal=Cancer%20Res&amp;volume=73&amp;issue=16&amp;pages=5016-5028">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">39.</span><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference 39. in text"
                           id="ref-39">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.39"
                             data-doi="10.1158/0008-5472.CAN-12-2447">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Baker</span>  <span class="cit-name-given-names">AM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bird</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Welti</span>  <span class="cit-name-given-names">JC</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis</span>.
                                 <abbr class="cit-jnl-abbrev">Cancer Res</abbr>.
                                 <span class="cit-pub-date">2013</span>;<span class="cit-vol">73</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">583</span>–<span class="cit-lpage">594</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=73/2/583"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">40.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.40">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Carpenter</span>  <span class="cit-name-given-names">RL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lo</span>  <span class="cit-name-given-names">HW</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Hedgehog pathway and GLI1 isoforms in human cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Discov Med</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">13</span>(<span class="cit-issue">69</span>):<span class="cit-fpage">105</span>–<span class="cit-lpage">113</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=22369969&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Hedgehog%20pathway%20and%20GLI1%20isoforms%20in%20human%20cancer&amp;author=RL%20Carpenter&amp;author=HW%20Lo&amp;publication_year=2012&amp;journal=Discov%20Med&amp;volume=13&amp;issue=69&amp;pages=105-113">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">41.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.41"
                             data-doi="10.1002/jcb.21194">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chen</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Du</span>  <span class="cit-name-given-names">XY</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Functional properties and intracellular signaling of CCN1/Cyr61</span>.
                                 <abbr class="cit-jnl-abbrev">J Cell Biochem</abbr>.
                                 <span class="cit-pub-date">2007</span>;<span class="cit-vol">100</span>(<span class="cit-issue">6</span>):<span class="cit-fpage">1337</span>–<span class="cit-lpage">1345</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/jcb.21194&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=17171641&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000245400300001&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Functional%20properties%20and%20intracellular%20signaling%20of%20CCN1%2FCyr61&amp;author=Y%20Chen&amp;author=XY%20Du&amp;publication_year=2007&amp;journal=J%20Cell%20Biochem&amp;volume=100&amp;issue=6&amp;pages=1337-1345">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">42.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.42">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Khachigian</span>  <span class="cit-name-given-names">LM</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Early growth response-1: blocking angiogenesis by shooting the messenger</span>.
                                 <abbr class="cit-jnl-abbrev">Cell Cycle</abbr>.
                                 <span class="cit-pub-date">2004</span>;<span class="cit-vol">3</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">10</span>–<span class="cit-lpage">11</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=14657654&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000222354900004&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Early%20growth%20response-1%3A%20blocking%20angiogenesis%20by%20shooting%20the%20messenger&amp;author=LM%20Khachigian&amp;publication_year=2004&amp;journal=Cell%20Cycle&amp;volume=3&amp;issue=1&amp;pages=10-11">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">43.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.43"
                             data-doi="10.2741/3573">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pardali</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">ten Dijke</span>  <span class="cit-name-given-names">P</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Transforming growth factor-beta signaling and tumor angiogenesis</span>.
                                 <abbr class="cit-jnl-abbrev">Front Biosci</abbr>.
                                 <span class="cit-pub-date">2009</span>;<span class="cit-vol">14</span>:<span class="cit-fpage">4848</span>–<span class="cit-lpage">4861</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.2741/3573&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19482591&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Transforming%20growth%20factor-beta%20signaling%20and%20tumor%20angiogenesis&amp;author=E%20Pardali&amp;author=P%20ten%20Dijke&amp;publication_year=2009&amp;journal=Front%20Biosci&amp;volume=14&amp;pages=4848-4861">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">44.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.44"
                             data-doi="10.1096/fj.03-0545fje">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zheng</span>  <span class="cit-name-given-names">PS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wen</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ang</span>  <span class="cit-name-given-names">LC</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Versican/PG-M G3 domain promotes tumor growth and angiogenesis</span>.
                                 <abbr class="cit-jnl-abbrev">FASEB J</abbr>.
                                 <span class="cit-pub-date">2004</span>;<span class="cit-vol">18</span>(<span class="cit-issue">6</span>):<span class="cit-fpage">754</span>–<span class="cit-lpage">756</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=fasebj&amp;resid=03-0545fjev1"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">45.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.45"
                             data-doi="10.1016/j.ygyno.2010.07.008">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zhu</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fejzo</span>  <span class="cit-name-given-names">MS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Anderson</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Periostin promotes ovarian cancer angiogenesis and metastasis</span>.
                                 <abbr class="cit-jnl-abbrev">Gynecol Oncol</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">119</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">337</span>–<span class="cit-lpage">344</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ygyno.2010.07.008&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=20688362&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000283206300032&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Periostin%20promotes%20ovarian%20cancer%20angiogenesis%20and%20metastasis&amp;author=M%20Zhu&amp;author=MS%20Fejzo&amp;author=L%20Anderson&amp;publication_year=2010&amp;journal=Gynecol%20Oncol&amp;volume=119&amp;issue=2&amp;pages=337-344">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">46.</span><a class="rev-xref-ref" href="#xref-ref-46-1" title="View reference 46. in text"
                           id="ref-46">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.46"
                             data-doi="10.1016/j.ccr.2008.11.012">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Erler</span>  <span class="cit-name-given-names">JT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bennewith</span>  <span class="cit-name-given-names">KL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cox</span>  <span class="cit-name-given-names">TR</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche</span>.
                                 <abbr class="cit-jnl-abbrev">Cancer Cell</abbr>.
                                 <span class="cit-pub-date">2009</span>;<span class="cit-vol">15</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">35</span>–<span class="cit-lpage">44</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ccr.2008.11.012&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19111879&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000262334800007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Hypoxia-induced%20lysyl%20oxidase%20is%20a%20critical%20mediator%20of%20bone%20marrow%20cell%20recruitment%20to%20form%20the%20premetastatic%20niche&amp;author=JT%20Erler&amp;author=KL%20Bennewith&amp;author=TR%20Cox&amp;publication_year=2009&amp;journal=Cancer%20Cell&amp;volume=15&amp;issue=1&amp;pages=35-44">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">47.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.47"
                             data-doi="10.1158/0008-5472.CAN-12-1223">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gao</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vahdat</span>  <span class="cit-name-given-names">LT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wong</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Microenvironmental regulation of epithelial-mesenchymal transitions in cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Cancer Res</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">72</span>(<span class="cit-issue">19</span>):<span class="cit-fpage">4883</span>–<span class="cit-lpage">4889</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=72/19/4883"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">48.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.48"
                             data-doi="10.1038/nature10694">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Malanchi</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Santamaria-Martinez</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Susanto</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Interactions between cancer stem cells and their niche govern metastatic colonization</span>.
                                 <abbr class="cit-jnl-abbrev">Nature</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">481</span>(<span class="cit-issue">7379</span>):<span class="cit-fpage">85</span>–<span class="cit-lpage">89</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/nature10694&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=22158103&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000298836900034&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Interactions%20between%20cancer%20stem%20cells%20and%20their%20niche%20govern%20metastatic%20colonization&amp;author=I%20Malanchi&amp;author=A%20Santamaria-Martinez&amp;author=E%20Susanto&amp;publication_year=2012&amp;journal=Nature&amp;volume=481&amp;issue=7379&amp;pages=85-89">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">49.</span><a class="rev-xref-ref" href="#xref-ref-49-1" title="View reference 49. in text"
                           id="ref-49">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.49"
                             data-doi="10.2174/156800908785699360">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ahmed</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Steele</span>  <span class="cit-name-given-names">JC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Herbert</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Tumor stroma as a target in cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Curr Cancer Drug Targets</abbr>.
                                 <span class="cit-pub-date">2008</span>;<span class="cit-vol">8</span>(<span class="cit-issue">6</span>):<span class="cit-fpage">447</span>–<span class="cit-lpage">453</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.2174/156800908785699360&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=18781891&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000263328800002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Tumor%20stroma%20as%20a%20target%20in%20cancer&amp;author=F%20Ahmed&amp;author=JC%20Steele&amp;author=JM%20Herbert&amp;publication_year=2008&amp;journal=Curr%20Cancer%20Drug%20Targets&amp;volume=8&amp;issue=6&amp;pages=447-453">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">50.</span><a class="rev-xref-ref" href="#xref-ref-50-1" title="View reference 50. in text"
                           id="ref-50">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.50">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schauer</span>  <span class="cit-name-given-names">IG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sood</span>  <span class="cit-name-given-names">AK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mok</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian
                                    cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Neoplasia</abbr>.
                                 <span class="cit-pub-date">2011</span>;<span class="cit-vol">13</span>(<span class="cit-issue">5</span>):<span class="cit-fpage">393</span>–<span class="cit-lpage">405</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=21532880&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000295448600001&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Cancer-associated%20fibroblasts%20and%20their%20putative%20role%20in%20potentiating%20the%20initiation%20and%20development%20of%20epithelial%20ovarian%20cancer&amp;author=IG%20Schauer&amp;author=AK%20Sood&amp;author=S%20Mok&amp;publication_year=2011&amp;journal=Neoplasia&amp;volume=13&amp;issue=5&amp;pages=393-405">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">51.</span><a class="rev-xref-ref" href="#xref-ref-51-1" title="View reference 51. in text"
                           id="ref-51">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.51"
                             data-doi="10.1158/1078-0432.CCR-07-0443">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dobbin</span>  <span class="cit-name-given-names">KK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zhao</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Simon</span>  <span class="cit-name-given-names">RM</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">How large a training set is needed to develop a classifier for microarray data?</span>
                                 <abbr class="cit-jnl-abbrev">Clin Cancer Res</abbr>.
                                 <span class="cit-pub-date">2008</span>;<span class="cit-vol">14</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">108</span>–<span class="cit-lpage">114</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=clincanres&amp;resid=14/1/108"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">52.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.52"
                             data-doi="10.1126/scitranslmed.3000313">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Koscielny</span>  <span class="cit-name-given-names">S</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Why most gene expression signatures of tumors have not been useful in the clinic</span>.
                                 <abbr class="cit-jnl-abbrev">Sci Transl Med</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">2</span>(<span class="cit-issue">14</span>):<span class="cit-fpage">14ps2</span>–<span class="cit-lpage">14ps2</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=FULL&amp;journalCode=scitransmed&amp;resid=2/14/14ps2"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">53.</span><a class="rev-xref-ref" href="#xref-ref-53-1" title="View reference 53. in text"
                           id="ref-53">↵</a>
                        
                        
                        <div class="cit ref-cit ref-book" id="cit-106.5.dju048.53">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Micheel</span>  <span class="cit-name-given-names">CM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nass</span>  <span class="cit-name-given-names">SJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Omenn</span>  <span class="cit-name-given-names">GS</span></span></li>
                              </ol><cite>.
                                 <span class="cit-source">Evolution of Translational Omics Lessons Learned and the Path Forward</span>.
                                 <span class="cit-publ-loc">Washington, DC</span>: <span class="cit-publ-name">National Academies Press</span>; <span class="cit-pub-date">2012</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Evolution%20of%20Translational%20Omics%20Lessons%20Learned%20and%20the%20Path%20Forward&amp;author=CM%20Micheel&amp;author=SJ%20Nass&amp;author=GS%20Omenn&amp;publication_year=2012">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">54.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-106.5.dju048.54"
                             data-doi="10.1016/j.critrevonc.2009.01.007">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sabatier</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Finetti</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cervera</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Gene expression profiling and prediction of clinical outcome in ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Crit Rev Oncol Hematol</abbr>.
                                 <span class="cit-pub-date">2009</span>;<span class="cit-vol">72</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">98</span>–<span class="cit-lpage">109</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.critrevonc.2009.01.007&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19249225&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Gene%20expression%20profiling%20and%20prediction%20of%20clinical%20outcome%20in%20ovarian%20cancer&amp;author=R%20Sabatier&amp;author=P%20Finetti&amp;author=N%20Cervera&amp;publication_year=2009&amp;journal=Crit%20Rev%20Oncol%20Hematol&amp;volume=72&amp;issue=2&amp;pages=98-109">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">55.</span><a class="rev-xref-ref" href="#xref-ref-55-1" title="View reference 55. in text"
                           id="ref-55">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.55"
                             data-doi="10.1093/jnci/dji168">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Simon</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Development and validation of therapeutically relevant multi-gene biomarker classifiers</span>.
                                 <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr>.
                                 <span class="cit-pub-date">2005</span>;<span class="cit-vol">97</span>(<span class="cit-issue">12</span>):<span class="cit-fpage">866</span>–<span class="cit-lpage">867</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=FULL&amp;journalCode=jnci&amp;resid=97/12/866"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">56.</span><a class="rev-xref-ref" href="#xref-ref-56-1" title="View reference 56. in text"
                           id="ref-56">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.56">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Baggerly</span>  <span class="cit-name-given-names">KA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Coombes</span>  <span class="cit-name-given-names">KR</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology</span>.
                                 <abbr class="cit-jnl-abbrev">Ann Appl Stat</abbr>.
                                 <span class="cit-pub-date">2009</span>;<span class="cit-vol">3</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">1309</span>–<span class="cit-lpage">1334</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=000283528200011&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Deriving%20chemosensitivity%20from%20cell%20lines%3A%20forensic%20bioinformatics%20and%20reproducible%20research%20in%20high-throughput%20biology&amp;author=KA%20Baggerly&amp;author=KR%20Coombes&amp;publication_year=2009&amp;journal=Ann%20Appl%20Stat&amp;volume=3&amp;issue=4&amp;pages=1309-1334">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">57.</span><a class="rev-xref-ref" href="#xref-ref-57-1" title="View reference 57. in text"
                           id="ref-57">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.57"
                             data-doi="10.1200/JCO.2007.15.1951">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Baggerly</span>  <span class="cit-name-given-names">KA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Coombes</span>  <span class="cit-name-given-names">KR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Neeley</span>  <span class="cit-name-given-names">ES</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2008</span>;<span class="cit-vol">26</span>(<span class="cit-issue">7</span>):<span class="cit-fpage">1186</span>–<span class="cit-lpage">1187</span>; author reply 1187–1188.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=FULL&amp;journalCode=jco&amp;resid=26/7/1186"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">58.</span><a class="rev-xref-ref" href="#xref-ref-58-1" title="View reference 58. in text"
                           id="ref-58">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.58"
                             data-doi="10.1038/nrg2825">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Leek</span>  <span class="cit-name-given-names">JT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Scharpf</span>  <span class="cit-name-given-names">RB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bravo</span>  <span class="cit-name-given-names">HC</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Tackling the widespread and critical impact of batch effects in high-throughput data</span>.
                                 <abbr class="cit-jnl-abbrev">Nat Rev Genet</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">11</span>(<span class="cit-issue">10</span>):<span class="cit-fpage">733</span>–<span class="cit-lpage">739</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/nrg2825&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=20838408&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000281911300013&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Tackling%20the%20widespread%20and%20critical%20impact%20of%20batch%20effects%20in%20high-throughput%20data&amp;author=JT%20Leek&amp;author=RB%20Scharpf&amp;author=HC%20Bravo&amp;publication_year=2010&amp;journal=Nat%20Rev%20Genet&amp;volume=11&amp;issue=10&amp;pages=733-739">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">59.</span><a class="rev-xref-ref" href="#xref-ref-59-1" title="View reference 59. in text"
                           id="ref-59">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.59"
                             data-doi="10.1093/jnci/djs203">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Swisher</span>  <span class="cit-name-given-names">EM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Taniguchi</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Karlan</span>  <span class="cit-name-given-names">BY</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Molecular scores to predict ovarian cancer outcomes: a worthy goal, but not ready for prime time</span>.
                                 <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr>.
                                 <span class="cit-pub-date">2012</span>;<span class="cit-vol">104</span>(<span class="cit-issue">9</span>):<span class="cit-fpage">642</span>–<span class="cit-lpage">645</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=FULL&amp;journalCode=jnci&amp;resid=104/9/642"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">60.</span><a class="rev-xref-ref" href="#xref-ref-60-1" title="View reference 60. in text"
                           id="ref-60">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.60"
                             data-doi="10.1056/NEJMoa0908806">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vergote</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Trope</span>  <span class="cit-name-given-names">CG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Amant</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">363</span>(<span class="cit-issue">10</span>):<span class="cit-fpage">943</span>–<span class="cit-lpage">953</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJMoa0908806&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=20818904&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000281441500007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Neoadjuvant%20chemotherapy%20or%20primary%20surgery%20in%20stage%20IIIC%20or%20IV%20ovarian%20cancer&amp;author=I%20Vergote&amp;author=CG%20Trope&amp;author=F%20Amant&amp;publication_year=2010&amp;journal=N%20Engl%20J%20Med&amp;volume=363&amp;issue=10&amp;pages=943-953">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">61.</span><a class="rev-xref-ref" href="#xref-ref-61-1" title="View reference 61. in text"
                           id="ref-61">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.61"
                             data-doi="10.1517/14728222.2010.525353">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chou</span>  <span class="cit-name-given-names">JL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chen</span>  <span class="cit-name-given-names">LY</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lai</span>  <span class="cit-name-given-names">HC</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">TGF-beta: friend or foe? The role of TGF-beta/SMAD signaling in epigenetic silencing of ovarian cancer and its implication
                                    in epigenetic therapy</span>.
                                 <abbr class="cit-jnl-abbrev">Expert Opin Ther Targets</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">14</span>(<span class="cit-issue">11</span>):<span class="cit-fpage">1213</span>–<span class="cit-lpage">1223</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1517/14728222.2010.525353&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=20925461&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000282964500007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=TGF-beta%3A%20friend%20or%20foe%3F%20The%20role%20of%20TGF-beta%2FSMAD%20signaling%20in%20epigenetic%20silencing%20of%20ovarian%20cancer%20and%20its%20implication%20in%20epigenetic%20therapy&amp;author=JL%20Chou&amp;author=LY%20Chen&amp;author=HC%20Lai&amp;publication_year=2010&amp;journal=Expert%20Opin%20Ther%20Targets&amp;volume=14&amp;issue=11&amp;pages=1213-1223">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">62.</span><a class="rev-xref-ref" href="#xref-ref-62-1" title="View reference 62. in text"
                           id="ref-62">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.62"
                             data-doi="10.1158/0008-5472.CAN-06-0683">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sunde</span>  <span class="cit-name-given-names">JS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Donninger</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wu</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta
                                    signaling in ovarian cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Cancer Res</abbr>.
                                 <span class="cit-pub-date">2006</span>;<span class="cit-vol">66</span>(<span class="cit-issue">17</span>):<span class="cit-fpage">8404</span>–<span class="cit-lpage">8412</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=66/17/8404"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">63.</span><a class="rev-xref-ref" href="#xref-ref-63-1" title="View reference 63. in text"
                           id="ref-63">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-106.5.dju048.63"
                             data-doi="10.1158/1078-0432.CCR-08-0196">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tothill</span>  <span class="cit-name-given-names">RW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tinker</span>  <span class="cit-name-given-names">AV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">George</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome</span>.
                                 <abbr class="cit-jnl-abbrev">Clin Cancer Res</abbr>.
                                 <span class="cit-pub-date">2008</span>;<span class="cit-vol">14</span>(<span class="cit-issue">16</span>):<span class="cit-fpage">5198</span>–<span class="cit-lpage">5208</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=clincanres&amp;resid=14/16/5198"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div>
            <div id="related">
               <h2>Related articles</h2>
               <ul class="related-list">
                  <div class="cit has-earlier-version">
                     <div class="cit-metadata"><span class="cit-first-element cit-section">Article<span class="cit-sep cit-sep-after-article-section">:</span> </span><ul class="cit-auth-list">
                           <li class="first-item"><span class="cit-auth cit-auth-type-author">Levi Waldron</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Benjamin Haibe-Kains</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Aedín C. Culhane</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Markus Riester</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Jie Ding</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Xin Victoria Wang</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Mahnaz Ahmadifar</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Svitlana Tyekucheva</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Christoph Bernau</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Thomas Risch</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Benjamin Frederick Ganzfried</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Curtis Huttenhower</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Michael Birrer</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li class="last-item"><span class="cit-sep cit-sep-last-separator">and </span><span class="cit-auth cit-auth-type-author">Giovanni Parmigiani</span></li>  
                        </ul><span class="cit-title">Comparative Meta-analysis of Prognostic Gene Signatures for Late-Stage Ovarian Cancer </span> <cite><abbr title="Journal of the National Cancer Institute" class="site-title">JNCI J Natl Cancer Inst</abbr> <span class="cit-print-date"><span class="cit-sep cit-sep-before-article-print-date">(</span>2014<span class="cit-sep cit-sep-after-article-print-date">)</span> </span><span class="cit-vol">106 </span><span class="cit-issue"><span class="cit-sep cit-sep-before-article-issue">(</span>5<span class="cit-sep cit-sep-after-article-issue">):</span> </span><span class="cit-elocation">dju049 </span><span class="cit-doi"><span class="cit-sep cit-sep-before-article-doi"> doi:</span>10.1093/jnci/dju049 </span><span class="cit-ahead-of-print-date"><span class="cit-sep cit-sep-before-article-ahead-of-print-date">first published online </span>April 3, 2014 </span><span class="cit-page-count"><span class="cit-sep cit-sep-before-article-page-count">(</span>12<span class="cit-sep cit-sep-after-article-page-count"> pages)</span> </span></cite>  
                     </div>
                     <div class="cit-extra"><span class="accesscheck jnci;106/5/dju049 abstract,full,reprint"></span> 
                        <ul class="cit-views">
                           <li class="first-item"><a href="/content/106/5/dju049.abstract" rel="abstract">Abstract</a></li>
                           <li><a href="/content/106/5/dju049.full" rel="full-text">Full Text (HTML)</a></li>
                           <li><a href="/content/106/5/dju049.full.pdf+html" rel="full-text.pdf">Full Text (PDF)</a></li>
                           <li class="last-item"><a href="/content/106/5/dju049/suppl/DC1" rel="supplemental-data"
                                 class="dslink-supplementary-data">Supplementary Data</a></li>
                        </ul>  
                     </div> 
                  </div>
                  <div class="cit has-earlier-version">
                     <div class="cit-metadata"><span class="cit-first-element cit-section">Solicited Editorial<span class="cit-sep cit-sep-after-article-section">:</span> </span><ul class="cit-auth-list">
                           <li class="first-item"><span class="cit-auth cit-auth-type-author">Brooke L. Fridley</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li><span class="cit-auth cit-auth-type-author">Devin C. Koeslter</span><span class="cit-sep cit-sep-separator">, </span></li>
                           <li class="last-item"><span class="cit-sep cit-sep-last-separator">and </span><span class="cit-auth cit-auth-type-author">Andrew K. Godwin</span></li>  
                        </ul><span class="cit-title">Individualizing Care for Ovarian Cancer Patients Using Big Data </span> <cite><abbr title="Journal of the National Cancer Institute" class="site-title">JNCI J Natl Cancer Inst</abbr> <span class="cit-print-date"><span class="cit-sep cit-sep-before-article-print-date">(</span>2014<span class="cit-sep cit-sep-after-article-print-date">)</span> </span><span class="cit-vol">106 </span><span class="cit-issue"><span class="cit-sep cit-sep-before-article-issue">(</span>5<span class="cit-sep cit-sep-after-article-issue">):</span> </span><span class="cit-elocation">dju080 </span><span class="cit-doi"><span class="cit-sep cit-sep-before-article-doi"> doi:</span>10.1093/jnci/dju080 </span><span class="cit-ahead-of-print-date"><span class="cit-sep cit-sep-before-article-ahead-of-print-date">first published online </span>April 3, 2014 </span><span class="cit-page-count"><span class="cit-sep cit-sep-before-article-page-count">(</span>2<span class="cit-sep cit-sep-after-article-page-count"> pages)</span> </span></cite>  
                     </div>
                     <div class="cit-extra"><span class="accesscheck jnci;106/5/dju080 pdf_extract,full,reprint"></span> 
                        <ul class="cit-views">
                           <li class="first-item"><a href="/content/106/5/dju080.extract" rel="extract">Extract</a></li>
                           <li><a href="/content/106/5/dju080.full" rel="full-text">Full Text (HTML)</a></li>
                           <li class="last-item"><a href="/content/106/5/dju080.full.pdf+html" rel="full-text.pdf">Full Text (PDF)</a></li>
                        </ul>  
                     </div> 
                  </div>
               </ul>
            </div><span id="related-urls"></span></div>
         <div id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="/content/106/5/dju044.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="/content/106/5/dju049.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="/content/106/5.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              <cite>
                                 <abbr title="JNCI Journal of the National Cancer Institute" class="slug-jnl-abbrev">
                                    <nlm:abbrev-journal-title xmlns:nlm="http://schema.highwire.org/NLM/Journal" abbrev-type="publisher">JNCI J Natl Cancer Inst</nlm:abbrev-journal-title></abbr><span class="slug-pub-date" itemprop="datePublished">
                                    (2014) 
                                    </span>
                                 
                                 <span class="slug-vol">
                                    106
                                    </span><span class="slug-issue">
                                    (5):
                                    </span><span class="slug-elocation">
                                    
                                    dju048
                                    </span>
                                 <span class="slug-doi-wrapper">
                                    
                                    doi:
                                    
                                    <span title="10.1093/jnci/dju048" class="slug-doi">10.1093/jnci/dju048</span>
                                    </span>
                                 </cite>
                              
                              
                              <span class="slug-metadata-note ahead-of-print">
                                 
                                 First published online
                                 
                                 <span class="slug-ahead-of-print-date">April 3, 2014</span>
                                 </span>
                              
                              
                              
                              
                              
                              
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="/content/106/5/dju048.abstract" rel="view-abstract">Abstract</a><span class="free">Free</span></li>
                        <li class="notice full-text-view-link"><span class="variant-indicator">» <span>Full Text (HTML)</span></span><span class="free">Free</span></li>
                        <li class="notice full-text-pdf-view-link"><a href="/content/106/5/dju048.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="free">Free</span></li>
                        <li><a href="/content/106/5/dju048/suppl/DC1" rel="supplemental-data"
                              class="dslink-supplementary-data">Supplementary Data</a></li>
                        <li class="cb-versions">
                           <div><span id="pap-all-versions-label">All Versions of this Article:</span><ol class="version-list">
                                 <li><a href="/content/early/2014/04/03/jnci.dju048">dju048v1</a></li>
                                 <li class="current-li"><span>106/5/dju048</span> <span class="current-version">most recent</span></li>
                              </ol>
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><span>Classifications</span></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search"
                                    href="/search?tocsectionid=Article&amp;sortspec=date&amp;submit=Submit">Article</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><span>Services</span></h4>
                     <ol>
                        <li class="usage-stats-link icon-link"><a href="/articleusage?gca=jnci;106/5/dju048" rel="nofollow">Article metrics</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jnci%3B106%2F5%2Fdju048&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/106/5/dju048.full">Alert me when cited</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=106/5/dju048&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/106/5/dju048.full">Alert me if corrected</a></li>
                        <li class="similar-link"><a href="/search?qbe=jnci%3Bdju048&amp;citation=Riester%20et%20al.%20106%20%285%29&amp;submit=yes">Find similar articles</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=jnci%3B106%2F5%2Fdju048&amp;link_type=ISI_RELATEDRECORDS"
                              id="cb-isi-similar-articles"
                              class="similar-link">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=24700803&amp;link_type=MED_NBRS"
                              class="similar-link">Similar articles in PubMed</a></li>
                        <li class="folder-link icon-link"><a href="/cgi/folders?action=addtofolder&amp;wherefrom=JOURNALS&amp;wrapped_id=jnci%3B106%2F5%2Fdju048">Add to my archive</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="/citmgr?gca=jnci%3B106%2F5%2Fdju048">Download citation</a></li>
                        <li><a class="request-permissions"
                              href="https://s100.copyright.com/AppDispatchServlet?publisherName=oup&amp;publication=jnci&amp;title=Risk%20Prediction%20for%20Late-Stage%20Ovarian%20Cancer%20by%20Meta-analysis%20of%201525%20Patient%20Samples%3A%20&amp;publicationDate=05%2F01%2F2014&amp;author=Markus%20Riester%2C%20Wei%20Wei%2C%20Levi%20Waldron%2C%20Aedin%20C.%20Culhane%2C%20Lorenzo%20Trippa%2C%20Esther%20Oliva%2C%20Sung-hoon%20Kim%2C%20Franziska%20Michor%2C%20Curtis%20Huttenhower%2C%20Giovanni%20Parmigiani%2C%20Michael%20J.%20Birrer&amp;copyright=Oxford%20University%20Press&amp;contentID=10.1093%2Fjnci%2Fdju048&amp;volumeNum=106&amp;issueNum=5&amp;startPage=&amp;endPage=&amp;orderBeanReset=true"
                              target="_blank">Request Permissions</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-cit">
                     <h4 class="cb-section-header"><span>Citing Articles</span></h4>
                     <ol>
                        <li class="hw-citing-link"><a href="/content/106/5/dju048.full?cited-by=yes&amp;legid=jnci;106/5/dju048#cited-by"
                              id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a href="/cgi/crossref-forward-links/106/5/dju048" rel="external-nw"
                              id="cb-crossref-citing-articles">Citing articles via CrossRef</a></li>
                        <li><a href="/scopus-links/jnci/106/5/dju048?access_num=/jnci/106/5/dju048"
                              rel="external-nw"
                              id="cb-scopus-citing-articles">Citing articles via Scopus</a></li>
                        <li><a href="/external-ref?access_num=%2Fjnci%2F106%2F5%2Fdju048&amp;link_type=ISI_CITING&amp;accnum_type=native"
                              rel="external-nw"
                              id="cb-isi-citing-articles">Citing articles via Web of Science</a></li>
                        <li><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/106/5/dju048.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><span>Google Scholar</span></h4>
                     <ol>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ARiester%20author%3AM.%22"
                              class="cb-art-gs-auth author-link">Articles by  Riester, M.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ABirrer%20author%3AM.J.%22"
                              class="cb-art-gs-auth author-link">Articles by  Birrer, M. J.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/106/5/dju048.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><span>PubMed</span></h4>
                     <ol>
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="/external-ref?access_num=24700803&amp;link_type=PUBMED"
                              class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Riester%20M&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Riester, M.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Wei%20W&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Wei, W.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Waldron%20L&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Waldron, L.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Culhane%20AC&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Culhane, A. C.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Trippa%20L&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Trippa, L.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Oliva%20E&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Oliva, E.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Kim%20Sh&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Kim, S. h.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Michor%20F&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Michor, F.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Huttenhower%20C&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Huttenhower, C.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Parmigiani%20G&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Parmigiani, G.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Birrer%20MJ&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Birrer, M. J.</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-rel">
                     <h4 class="cb-section-header"><span>Related Content</span></h4>
                     <ol>
                        <li><a href="#related">Related articles in this journal</a></li>
                        <li><a href="/content/106/5/dju048.full?related-urls=yes&amp;legid=jnci;106/5/dju048#related-urls"
                              id="cb-related-urls">Load related web page information</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-soc">
                     <h4 class="cb-section-header"><span>Share</span></h4>
                     <ol>
                        <li><a href="/email?gca=jnci%3B106%2F5%2Fdju048&amp;current-view-path=/content/106/5/dju048.full">
                              Email this article</a></li>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/106/5/dju048&amp;title=Risk%20Prediction%20for%20Late-Stage%20Ovarian%20Cancer%20by%20Meta-analysis%20of%201525%20Patient%20Samples+--+Riester%20et%20al.%20106%20%285%29+--+jnci&amp;doi=10.1093/jnci/dju048&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                                            alt="Add to CiteULike"
                                            title="CiteULike" /></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/106/5/dju048&amp;title=Risk%20Prediction%20for%20Late-Stage%20Ovarian%20Cancer%20by%20Meta-analysis%20of%201525%20Patient%20Samples+--+Riester%20et%20al.%20106%20%285%29+--+jnci&amp;doi=10.1093/jnci/dju048&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                                            alt="Add to Delicious"
                                            title="Delicious" /></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/short/106/5/dju048&amp;title=Risk%20Prediction%20for%20Late-Stage%20Ovarian%20Cancer%20by%20Meta-analysis%20of%201525%20Patient%20Samples+--+Riester%20et%20al.%20106%20%285%29+--+jnci&amp;doi=10.1093/jnci/dju048&amp;link_type=FACEBOOK"
                                       class="sb-facebook"
                                       rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                                            title="Facebook" /></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/106/5/dju048&amp;title=Risk%20Prediction%20for%20Late-Stage%20Ovarian%20Cancer%20by%20Meta-analysis%20of%201525%20Patient%20Samples+--+Riester%20et%20al.%20106%20%285%29+--+jnci&amp;doi=10.1093/jnci/dju048&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="/shared/img/common/social-bookmarking/googleplus.jpg" alt="Add to Google+"
                                            title="Google+" /></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/106/5/dju048&amp;title=Risk%20Prediction%20for%20Late-Stage%20Ovarian%20Cancer%20by%20Meta-analysis%20of%201525%20Patient%20Samples+--+Riester%20et%20al.%20106%20%285%29+--+jnci&amp;doi=10.1093/jnci/dju048&amp;link_type=MENDELEY"><img src="/shared/img/common/social-bookmarking/mendeley.gif" alt="Add to Mendeley"
                                            title="Mendeley" /></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/106/5/dju048&amp;title=Risk%20Prediction%20for%20Late-Stage%20Ovarian%20Cancer%20by%20Meta-analysis%20of%201525%20Patient%20Samples+--+Riester%20et%20al.%20106%20%285%29+--+jnci&amp;doi=10.1093/jnci/dju048&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                                            title="Twitter" /></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#sec-5">Methods</a></li>
                        <li><a href="#sec-15">Results</a></li>
                        <li><a href="#sec-21">Discussion</a></li>
                        <li><a href="#sec-22">Funding</a></li>
                        <li><a href="#notes-1">Notes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div id="col-3">
            
            <div id="col-3-qs" class="sidebar-qs">
               
               
               <form class="searchbox" action="/search" method="get">
                  <p>Search this journal:</p>
                  <div>
                     	
                     	
                     	<input value="" type="text" name="fulltext" id="header-qs-input" />
                     <input type="hidden" name="submit" value="yes" />
                     
                     <input class="inline_button" type="image" alt="Go" src="/publisher/img/buttons/go.gif" />
                     
                     <div class="adv-search-link"><a href="/search">Advanced »</a></div>
                     
                     
                  </div>
               </form>
               
            </div>
            <div class="cb-contents">
               
               <div id="sidebar-current-issue" class="content-box">
                  	
                  <h3 class="cb-contents-header">Current Issue</h3>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           	      <a href="/content/current"><span>
                                 		  <span class="current-issue-date">
                                    October 2015
                                    </span><span class="toc-citation-volume">
                                    
                                    107
                                    </span><span class="toc-citation-issue">(10)</span>
                                 		  
                                 		</span></a>
                           	    
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           <a href="/content/current"><img src="/content/107/10.cover.gif" alt="JNCI J Natl Cancer Inst" id="cover" /></a>
                           
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section sidebar-etoc-link">
                     	  
                     <ol>
                        <li><a href="/cgi/alerts/etoc">Alert me to new issues</a></li>
                     </ol>
                     	
                  </div>
                  
               </div>
               
            </div>
            
            <div id="second">
               
               <div class="ad_hidden" id="oas_right1">
                  <iframe id="id_advertframe_right1"
                          src="/resource/htmlfiles/advert.html?p=Right1&amp;u=jnci.oxfordjournals.org/content/106/5/dju048.full"
                          width="0"
                          height="0"
                          frameborder="0"
                          scrolling="no"
                          class="resize_ad"></iframe>
                  
               </div>
               
               <div class="features">
                  
                  <div class="feature separator_after first">
                     
                     <h2 id="the_journal" title="The Journal"><span>The Journal</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/about.html" rel=""
                              title="About this journal">About this journal</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/contact_us.html" rel=""
                              title="Contact Us">Contact Us</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/rights_permissions.html"
                              rel=""
                              title="Rights &amp; Permissions">Rights &amp; Permissions</a>
                           
                        </li>
                        <li>
                           <a href="HTTP://www.oxfordjournals.org/access_purchase/dispatch_dates.html#JNCI.JP"
                              rel=""
                              title="Dispatch date of next issue">Dispatch date of next issue</a>
                           
                        </li>
                        <li>
                           <a href="http://publicationethics.org/" rel=""
                              title="This journal is a member of the Committee on Publication Ethics (COPE)">This journal is a member of the Committee on Publication Ethics (COPE)</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/mobile_faqs.html" rel=""
                              title="We are mobile – find out more">We are mobile – find out more</a>
                           
                        </li>
                        <li>
                           <a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;t732=469986&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102"
                              rel=""
                              title="Journals Career Network">Journals Career Network</a>
                           
                        </li>
                     </ul>
                     
                     <p>
                        <a href="http://www.oxfordjournals.org/our_journals/jnci/episodes_2012.html">
                           <img alt="Podcast Logo" style="float:left"
                                src="http://www.oxfordjournals.org/podcasts/podcast_icon_35x35.gif" />JNCI Podcast</a>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Connect with us!</h3>
                     <a href="https://twitter.com/JNCI_Now">
                        <img class="small_margin" alt="Connect with us on Twitter!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/connect_twitter.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     <a href="https://www.facebook.com/thejnci">
                        <img class="small_margin" alt="Connect with us on Facebook!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/facebook.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     
                     <p>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Editor-in-Chief</h3>
                     
                     <p>Carmen J. Allegra</p>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/editorial_board.html"
                              rel=""
                              title="View full editorial board">View full editorial board</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Impact factor: 12.583</h3>
                     
                     <h3 class="five_year">5-Yr impact factor: 13.584</h3>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h3>For the Media</h3>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/press_room.html" rel=""
                              title="JNCI PRESS ROOM">JNCI PRESS ROOM</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="for_authors" title="For Authors"><span>For Authors</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/for_authors/index.html"
                              rel=""
                              title="Instructions to authors">Instructions to authors</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html"
                              rel=""
                              title="Self Archiving/Public Access Policy">Self Archiving/Public Access Policy</a>
                           
                        </li>
                     </ul>
                     <a href="http://www.oxfordjournals.org/oxfordopen/ ">
                        <img alt="Open access options for authors - visit Oxford Open"
                             src="http://www.oxfordjournals.org/resource/image/promos/oxford_open_small.gif" />
                        </a>
                     <a href="http://www.oxfordjournals.org/oxfordopen/funder_policies/">
                        <img alt="RCUK Wellcome Trust Open Access"
                             src="http://www.oxfordjournals.org/resource/image/wellcome-trust-180x100.jpg" />
                        </a>
                     
                     <p>Open access options for authors - visit <a href="http://www.oxfordjournals.org/oxfordopen/">Oxford Open</a>
                        
                     </p>
                     <a href="http://publicaccess.nih.gov/submit_process_journals.htm">
                        <img alt="PMC Logo" src="http://www.oxfordjournals.org/resource/image/pmc-logo.gif" />
                        </a>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://publicaccess.nih.gov/submit_process_journals.htm" rel=""
                              title="This journal enables compliance with the NIH Public Access Policy">This journal enables compliance with the NIH Public Access Policy</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="alerting_services" title="Alerting Services"><span>Alerting Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email table of contents">Email table of contents</a>
                           
                        </li>
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email Advance Access">Email Advance Access</a>
                           
                        </li>
                        <li>
                           <a href="http://jnci.oxfordjournals.org/help/citetrack/index.dtl" rel=""
                              title="CiteTrack">CiteTrack</a>
                           
                        </li>
                        <li>
                           <a href="/rss" rel="" title="XML RSS feed">XML RSS feed</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="corporate_services" title="Corporate Services"><span>Corporate Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/advertising.html" rel=""
                              title="Advertising sales">Advertising sales</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/reprints.html" rel=""
                              title="Reprints">Reprints</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/classifiedadinprint.html"
                              rel=""
                              title="Classified Advertising">Classified Advertising</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
               </div>
               <script type="text/javascript">var taxonomies = ["MED00300"];</script>
               </div>
            
            <div class="most-links-box js-marker">
               
               <div class="most-header">
                  
                  <h3>Most</h3>
                  
               </div>
               
               <ul>
                  <li class="most-cur-sel">
                     <h4>Most Read</h4>
                     	  
                     <div class="most-list">
                        	    
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/6/443?rss=1&amp;ssource=mfr">Breast Density and Cancer Risk: What Is the Relationship?</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/9/713?rss=1&amp;ssource=mfr">The Female Prostate</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/91/14/1194?rss=1&amp;ssource=mfr">Tobacco Smoke Carcinogens and Lung Cancer</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/107/6/djv048?rss=1&amp;ssource=mfr">Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity,
                                 Poverty, and State</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/105/23/1799?rss=1&amp;ssource=mfr">Elevated Plasma Vitamin B12 Levels as a Marker for Cancer: A Population-Based Cohort Study</a></li>
                        </ol>
                        	    <a href="http://jnci.oxfordjournals.org/reports/mfr1.dtl" class="view-all">» View all Most Read articles</a>
                        	  
                     </div>
                     	
                  </li>
                  <li>
                     <h4>Most Cited</h4>
                     	
                     <div class="most-list">
                        	  
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/3/205?rss=1&amp;ssource=mfc">New Guidelines to Evaluate the Response to Treatment in Solid Tumors</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/18/1371?rss=1&amp;ssource=mfc">Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/85/5/365?rss=1&amp;ssource=mfc">The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International
                                 Clinical Trials in Oncology</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/13/1107?rss=1&amp;ssource=mfc">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/1/4?rss=1&amp;ssource=mfc">What Is the Evidence That Tumors Are Angiogenesis Dependent?</a></li>
                        </ol>
                        	  <a href="http://jnci.oxfordjournals.org/reports/mfc1.dtl" class="view-all">» View all Most Cited articles</a>
                        	
                     </div>
                     
                  </li>
               </ul>
               
            </div>
            
            
            
         </div>
         
         
         
         <div id="oas_bottom" class="ad_hidden">
            <iframe id="id_advertframe_bottom"
                    src="/resource/htmlfiles/advert.html?p=Bottom&amp;u=jnci.oxfordjournals.org/content/106/5/dju048.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         
         
         
         
         <div id="secondary_footer">
            
            <div id="issn">Online ISSN 1460-2105 - Print ISSN 0027-8874</div>
            
            
            <div id="copyright"><a href="http://www.oxfordjournals.org/our_journals/terms.html">Copyright ©</a> 
               <span>2015</span> Oxford University Press
               
            </div>
            
         </div>
         
         <div id="primary_footer">
            
            <div id="site_logo">
               <strong><span>Oxford Journals</span></strong>
               <em><span>Oxford University Press</span></em>
               
            </div>
            
            
            <div id="third_nav">
               
               <ul>
                  <li><a href="http://www.oxfordjournals.org/site_map.html">Site Map</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/privacy_policy.html">Privacy Policy</a></li>
                  <li><a href="http://global.oup.com/cookiepolicy/?siteid=journals">Cookie Policy</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/legal_notices.html">Legal Notices</a></li>
                  <li><a href="http://www.oxfordjournals.org/faq/">Frequently Asked Questions</a></li>
               </ul>
               
            </div>
            
            
            <div id="other_oup_sites">
               
               <form action="http://www.oxfordjournals.org/service/redirect">
                  <div>
                     <label for="site_list">Other Oxford University Press sites:</label>
                     <select name="url" id="site_list">
                        <option value="http://www.oup.com">Oxford University Press</option>
                        <option value="http://www.oxfordjournals.org/china/">Oxford Journals China</option>
                        <option value="http://www.oxfordjournals.org/japan/">Oxford Journals Japan</option>
                        <option value="http://www.oup.com/uk/academic">Academic &amp; Professional books</option>
                        <option value="http://www.oup.com/oxed">Children's &amp; Schools Books</option>
                        <option value="http://www.oup.com/uk/dictionaries">Dictionaries &amp; Reference</option>
                        <option value="http://www.oup.co.uk/newdnb/">Dictionary of National Biography</option>
                        <option value="http://www.oup.com/uk/digital_reference">Digital Reference</option>
                        <option value="http://www.oup.com/elt/">English Language Teaching</option>
                        <option value="http://www.oup.com/uk/textbooks">Higher Education Textbooks</option>
                        <option value="http://www.oup.co.uk/ieu/">International Education Unit</option>
                        <option value="http://www.oup.com/uk/law">Law</option>
                        <option value="http://www.oup.com/uk/medicine">Medicine</option>
                        <option value="http://www.oup.com/uk/music">Music</option>
                        <option value="http://www.oup.com/online">Online Products &amp; Publishing</option>
                        <option value="http://oxfordbibliographiesonline.com">Oxford Bibliographies Online</option>
                        <option value="http://oxforddictionaries.com">Oxford Dictionaries Online</option>
                        <option value="http://www.oed.com">Oxford English Dictionary</option>
                        <option value="http://www.oxfordlanguagedictionaries.com">Oxford Language Dictionaries Online</option>
                        <option value="http://www.oxfordscholarship.com">Oxford Scholarship Online</option>
                        <option value="http://www.oup.com/uk/reference">Reference</option>
                        <option value="http://www.oup.com/uk/rights">Rights and Permissions</option>
                        <option value="http://www.oup.com/uk/booksellers">Resources for Retailers &amp; Wholesalers</option>
                        <option value="http://www.oup.com/uk/corporate">Resources for the Healthcare Industry</option>
                        <option value="http://www.oup.com/vsi">Very Short Introductions</option>
                        <option value="http://www.oup.com/worldsclassics">World's Classics</option></select>
                     
                     <input type="image" src="/resource/image/buttons/go.gif" alt="Go"
                            class="inline_button" />
                     
                  </div>
               </form>
               
            </div>
            
         </div>
         <script type="text/javascript"
                 src="http://gab.cookie.oup.com/aws-cookie/oup.cookiepolicy.pack.js"
                 defer="defer"></script>
         
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jquery-ui.min.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jcarousellite.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/pf_oiunderbarinit.js"
                 type="text/javascript"></script>
         <script defer="defer" src="/resource/js/underbar_local.js" type="text/javascript"></script>
         <script defer="defer" type="text/javascript">
    function fnc_onDomLoaded() {
        var query_context = getQueryContext();
        PF_initOIUnderbar(query_context,":QS:default","","JRN"); 
        PF_insertOIUnderbar(0);
    };
    if (window.addEventListener) { 
        window.addEventListener('load', fnc_onDomLoaded, false); 
    } else if (window.attachEvent) { 
        window.attachEvent('onload', fnc_onDomLoaded); 
    } 
</script>
         <noscript><img src="//ouptag.scholarlyiq.com/ntpagetag.gif?js=0" height="1" width="1"
                 border="0"
                 hspace="0"
                 vspace="0"
                 alt="" /></noscript><script type="text/javascript" src="//ouptag.scholarlyiq.com/ntpagetag.js"></script><script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script type="text/javascript">
        try {
        var pageTracker = _gat._getTracker("UA-189672-16");
        pageTracker._setDomainName(".oxfordjournals.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   </body>
</html>